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ABSTRACT 
 
Many studies have focused on investigating deviations from additive interaction of 
two dichotomous risk factors on a binary outcome. There is, however, a gap in the 
literature with respect to interactions on the additive scale of >2 risk factors. In this 
paper, we present an approach for examining deviations from additive interaction 
among three on more binary exposures. The relative excess risk due to interaction 
(RERI) is used as measure of additive interaction. First, we concentrate on three risk 
factors - we propose to decompose the total RERI to: the RERI owned to the joint 
presence of all 3 risk factors and the RERI of any two risk factors, given that the third 
is absent. We then extend this approach, to >3 binary risk factors. For illustration, we 
use a sample from data from the Greek EPIC cohort and we investigate the 
association with overall mortality of Mediterranean diet, body mass index (BMI), and, 
smoking.  Our formulae enable better interpretability of any evidence for deviations 
from additivity owned to more than two risk factors and provide simple ways of 
communicating such results from a public health perspective by attributing any excess 
relative risk to specific combinations of these factors.  
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INTRODUCTION 
Four decades ago, Rothman stated that, as more than one risk factors are 
eventually established for the etiology of a specific health outcome, epidemiologists 
will need to pay more attention to the issue of interaction (synergy or antagonism) 
between these factors[1]. This is particularly relevant in the field of genetic 
epidemiology, as scientists focus on the study of thousands of genes and of their 
interactions with environmental factors[2-3]. 
Measuring interaction on the additive scale is more important from a public 
health perspective[4-7], because, in this context, two risk factors are independent, when 
the number of disease cases is not dependent on the extent to which these factors act 
together[5]. If, for example, the number (or rate) of hospitalizations for a disease when 
individuals are exposed into two risk factors is greater than the sum of hospitalizations 
for this disease of the people exposed only to one of these factors, then the public health 
services would be challenged to carry extra weight due to this interaction, which is 
measured as a deviation from additivity of the effects of these factors. 
Nevertheless, the usual practice has been to refer to statistical interaction when 
studying interaction between risk factors[7].  Under this concept, interaction is 
measured on either additive or multiplicative scale, depending solely on the form of the 
underlying model used, rather than on a-priori consideration for the expected type of 
associations between these exposures and the outcome.  
The deviation from additivity of the effects between two variables has been 
proposed by Rothman[8] and further explored by others[2-3,9-22]. Surprisingly, the 
study of additive interaction of >2 factors has not been studied adequately, even if it 
would enable better understanding of the joint action of many factors for the 
development of a specific disease. This may have occurred because conceptualizing the 
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features of multi-way interaction is challenging (e.g. a modification of an interaction 
between two variables by a third variable is not easy to understand and sometimes the 
rationale for assessing this effect is not there). Apart from the studies related to multi-
way interaction in the sufficient-cause framework[23-25], to the best of our knowledge, 
there are only three relevant publications that have focused only on practical illustration 
of deviation from additivity of the effects of three risk factors[26-28]. 
In this paper, we aim to fill this gap in the literature and provide useful tools for 
researchers who wish to focus on the joint action of >2 binary factors. We highlight the 
questions of interest in the study of joint action of 3 factors, we give answers by 
introducing useful indexes for additive interaction, accompanied by the corresponding 
recommendation for the conduction these of analyses, and we then extend the methods 
to >3 factors.  We illustrate our theoretical arguments using data from the Greek-EPIC 
study and we provide an easy-to-use code in Stata for the implementation of these 
methods. 
 
 
METHODS 
Definitions 
Consider n dichotomous Xi , i=1,..,n variables as risk factors for a disease D with Xi = 
(0,1). Let D+ and D- denote the presence/absence of D, and Xi+, Xi-, the presence (Xi 
=1) or absence (Xi =0) of Xi.  The relative risk of D+ for any combination of the 
presence or absence of X1, X2, ... Xn,  as compared to their absence is denoted by 
RRX1#X2#…Xn# , where # = +/- and the corresponding excess relative risk by 
ERRX1#X2#…Xn# with 
ERRX1#X2#…Xn# = RRX1#X2#…Xn# − RRX1−X2−⋯Xn−                 , i.e.  
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ERRX1#X2#…Xn# = RRX1#X2#…Xn# − 1 
For the investigation of any deviation from additivity of the effects of two risk 
factors, we focus on the contrast between 
RRX1+X2+ − RRX1−X2− vs  (RRX1+X2− − RRX1−X2−) − (RRX1−X2+ − RRX1−X2−) 
i.e. the excess risk from the situation when two risk factors act jointly versus the extra 
risk of the occasions that each of them acts separately  
So a measure for additive interaction would be the relative excess risk due to interaction 
RERI2(X1,X2) 
RERI(X1, X2) = ERRX1+X2+ − ERRX1+X2− − ERRX1−X2+ 
             =  (RRX1+X2+ − RRX1−X2−) − (RRX1+X2− − RRX1−X2−) − (RRX1−X2+ − RRX1−X2−) 
              = RRX1+X2+ −  RRX1+X2− − RRX1−X2+ + 1 
which indicates whether the effect of 2 risk factors that act jointly is greater (RERI2>0), 
equal (RERI2=0) or lower (RERI2<0) than the sum of their individual effect (super-
additive, additive or sub-additive effects respectively).  
It is crucial to highlight that the factors cannot be protective, because the 
calculation of additive interaction will be wrong, as a relative risk is between 0 and 1 
for a protective factor, while it can be from 1 to infinity for a risk factor. Imagine 2 
drugs with additive effects (RERI2=0) on CVD, each of those reducing the CVD risk 
by 75% (i.e. RR10,RR01=0.25). We cannot use the RERI2 index, because we would 
calculate that RR11 is negative (RR11=–0. 5)! Instead, we should recode these factors 
into risk (i.e. the effect of not taking the drugs) and apply the calculations (see [9] and 
Appendix, Section B and D). 
Additionally, if one wants to focus on the multiplicative interaction of 2 risk factors, 
then the contrast of interest would be  
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RRX1+X2+      vs          RRX1+X2− ∗ RRX1−X2+ 
i.e. the comparison of the relative risk when two risk factors act jointly versus the 
multiplication of the risk of the occasions that each of them acts separately 
The index of multiplicative interaction would be  
𝐼2 =
RRX1+X2+
RRX1+X2− ∗ RRX1−X2+
 
For more details, see ref [16].  
In Appendix (Section E), we show i) that multiplicative or super-multiplicative effects 
imply super-additive effects and ii) that additive or sub-additive effects imply sub-
multiplicative effects for 2-way interactions. 
 
From the two to the three-way interaction on the additive scale 
Imagine now that the question of interest is whether 3 risk factors “interact” 
on the additive scale. How should we face that problem?  
The first answer we should give would be an extension of the previous 
methods for the construction of RERI2. Now, we should take into account the extra 
risk due to the joint presence of the three risk factors and compare it with the sum of 
the excess risks caused by each risk factor separately, i.e. 
(RRX1+X2+X3+ − RRX1−X2−X3−)   vs    (RRX1+X2−X3− − RRX1−X2−X3−)   
                                                                   +(RRX1−X2+X3− − RRX1−X2−X3−)  
                                                                   +(RRX1−X2−X3+ − RRX1−X2−X3−)  
 
In other words, we should extend the RERI definition to three risk factors X1, X2 and 
X3, and calculate the total relative excess risk due to interaction (TotRERI3) , 
TotRERI3(X1, X2, X3) = (RRX1+X2+X3+ − RRX1−X2−X3−) − (RRX1+X2−X3− − RRX1−X2−X3−)  
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                             −(RRX1−X2+X3− − RRX1−X2−X3−) − (RRX1−X2−X3+ − RRX1−X2−X3−) 
            = RRX1+X2+X3+ − RRX1+X2−X3− − RRX1−X2+X3− − RRX1−X2−X3+ + 2          (1) 
The total relative excess risk due to interaction (TotRERI3) is calculated by comparing 
the joint effect of three risk factors to the situation when each one acts separately. It 
allows us to understand whether these variables have super-additive, additive or sub-
additive effects.  
The next issue that we should wonder is about the index for 3-way additive 
interaction, beyond two-way interactions. The super/sub additivity of the effects of 3 
risk factors (1) is due either to the 3-way interaction (RERI3) of the 3 risk factors, or 
to the 2-way interaction of the 2 risk factors, when the 3rd is absent. To calculate 
RERI3, one needs to subtract RERI2(X1,X2 | X3=0), RERI2(X1,X3 | X2=0) and 
RERI2(X2,X3 | X1=0) from TotRERI3, i.e. 
RERI3(X1, X2, X3) = TotRERI3(X1, X2, X3)  
                    −RERI2(X1, X2|X3 = 0) − RERI2(X1, X3|X2 = 0) − RERI2(X2, X3|X1 = 0) 
The relative excess risk due to interaction is the measure of the three-way interaction. 
This index indicates whether there is positive/negative 3-way interaction on the 
additive scale, which is explicitly due to the joint presence of all three factors, in other 
words, measures the 3-way interaction, beyond the possible 2 way interactions. 
Additionally, , TotRERI3(X1, X2, X3) expresses the sum of the 3-way interaction and 
all 2-way interactions and , that is 
TotRERI3(X1, X2, X3) = RERI3(X1, X2, X3) 
                 +RERI2(X1, X2|X3 = 0) + RERI2(X1, X3|X2 = 0) + RERI2(X2, X3|X1 = 0)    
(2) 
Of note, TotRERI3 may be zero as the result of 2-way interactions that cancel out with 
3-way interaction. 
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Moreover, to calculate the three-way interaction (RERI3(X1, X2, X3)),we have to 
combine (1) and (2) (see Appendix, section A) to estimate 
RERI3(X1, X2, X3)  = RRX1+X2+X3+ 
                                      −RRX1+X2+X3− − RRX1+X2−X3+ − RRX1−X2+X3+ 
                                      +RRX1+X2−X3− + RRX1−X2+X3− + RRX1−X2−X3+  
                                     −RRX1−X2−X3−                                                                                             (3) 
        Finally, we note that the three-way interaction (see 3) reflects the contrast of 
interactions between two variables over the strata of a third.  We show in Appendix 
(Section A) that the corresponding formulae are 
RERI3(X1, X2, X3) = (RERI2(Xj, Xk|Xl = 1) ∗ RRXj−Xk−Xl+) − RERI2(Xj, Xk|Xl = 0)   (4) 
because 
RERI(Xj, Xk|Xl = 1) =
( RRXj+Xk+Xl+ − RRXj+Xk−Xl+ − RRXj−Xk+Xl+ + RRXj−Xk−Xl+)
RRXj−Xk−Xl+
 
given that RRXj−Xk−Xl− is the reference relative risk. 
where j,k,l = (1,2,3) and j≠k, j≠l, k≠l. 
 
  The two-way interactions, given the third factor is absent 
(RERI2(X1, X2|X3 = 0), RERI2(X1, X3|X2 = 0) and RERI2(X2, X3|X1 = 0), as well as 
the corresponding interactions when the 3rd risk factor is present (RERI2(X1, X2|X3 =
1), RERI2(X1, X3|X2 = 1) and RERI2(X2, X3|X1 = 1)) are important measures in the 
study of joint effects of 3 factors. They are very helpful in better specifying under which 
conditions 2 of the 3 factors interact.  In the classic framework of 2-way interactions, 
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researchers report a specific value for RERI between two variables X1 and X2. 
However, this value may not be constant across the strata of a 3rd factor X3 and to check 
for that issue (which was named “the uniqueness problem” by Skrondal[12]), we can 
calculate RERI2(X1, X2|X3 = 0) and RERI2(X1, X2|X3 = 1). 
 In the Appendix (section B), we show how to calculate the formulae of all these 
indexes for additive interaction in the presence of 3 risk factors (both 2 and 3-way), 
when applying Cox regression. The formulae are the same when using logistic 
regression as well. Finally, we provide user-friendly Stata code that would be useful for 
researchers who wish to implement these methods and calculate all possible 2- and 3-
way interactions (Appendix, section B). Below we briefly present some 
recommendations on how to implement 3-way interaction analysis [in Appendix 
(Section D), we present more details on each of these steps]. 
1) Conduct the analysis with the exposure of interest, without using any 
interaction term to check whether the exposures are risk or protective factors. 
If any of the exposures appeared to be a protective factor, then recode it to a 
risk factor 
2) Perform the analysis of the 3 risk factors, this time using their interaction 
terms 
3) Compute TotRERI3 and find out whether the effects of the risk factors are 
super- or sub-additive  
4) Estimate RERI3 to check whether any deviation from additivity of the three 
risk factors (TotRERI3) is due to the 3-way interaction, beyond the two way 
interactions [see equation (3)].  
5) Calculate the two way interactions, given the 3rd is absent [from (A.SB.4)–
(A.SB.6), Appendix, Section B) to test whether any deviation from additivity 
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of the three risk factors (expressed through TotRERI3) is attributed to additive 
interaction of the two risk factors [(see equation (3)].  
6) Compute the two way interactions, given the 3rd is present (from (A.SB.7)–
(A.SB.9) in Appendix, Section B) to check to what extent the two-way 
interactions vary across the strata of a third variable. 
7) Check whether each risk factor increase risk in all possible combinations with 
other risk factors, i.e. whether there is qualitative interaction (when the 
exposure is a risk factor for a specific outcome for one subgroup, but a 
protective factor for another subgroup). This information would be useful for 
decision making for public health purposes, because, in such instances, we 
should not treat all the subgroups, but only those people for which the 
medication is beneficial. For more details, see [16] and Appendix (Section B 
and F). 
 
From the three to the multi-way interaction on the additive scale 
When studying the multi-way interaction of n risk factors X1,X2,...,Xn, on the additive 
scale, we can calculate the total relative excess risk due to interaction (TotRERIn), as a 
generalization of equation 1. TotRERIn expresses the contrast of the excess risk from 
the situation when all risk factors act jointly versus the extra risk of the occasion that 
each of them acts separately, i.e. 
When studying the multi-way interaction of n risk factors X1, X2 ..., Xn, on the additive 
scale, the comparison of interest is 
(RRX1+X2+⋯Xn+ − RRX1−X2−⋯Xn−)   vs    (RRX1+X2−⋯Xn− − RRX1−X2−⋯Xn−)   
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                                                                          +(RRX1−X2+⋯Xn− − RRX1−X2−⋯Xn−)  
                                                                          + ⋯  
                                                                          +(RRX1−X2−⋯Xn+ − RRX1−X2−⋯Xn−)  
The difference from this comparison should correspond to the total relative excess risk 
due to interaction, that is the sum of the n-way interaction and all the (n-1)-,      (n-
2)-, ..., 2-way interactions of these risk factors. In other words, we have that, 
TotRERIn(X1, X2, … , Xn) =  ERRX1+X2+⋯Xn+   
                                −ERRX1+X2−⋯Xn− − ERRX1−X2+⋯Xn− − ⋯ − ERRX1−X2−⋯Xn+         
(5) 
Given that TotRERIn is attributed to all potential interactions between the n variables, 
in other words it can be expressed as the sum of the n-way interaction and all the (n-1)-
, (n-2)-, …, 2-way interactions (see Appendix, section C), i.e. 
TotRERIn(X1, X2, … , Xn) = RERIn(X1, X2, … , Xn) 
                                                +  ∑ RERIn−1(X1, X2, … , Xn|1 of the Xi = 0)
( nn−1)
 
                                                +  ∑ RERIn−2(X1, X2, … , Xn|2 of the Xi = 0)
( nn−2)
 
                                                   ... 
                                                +  ∑ RERI2(X1, X2, … , Xn|(n − 2) of the Xi = 0)
(n2)
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If we want to compute the n-way additive interaction RERIn, without the contribution 
of all lower order interactions, then for 1≤i≤n and  1≤k≤n, we let  
RR(k)  equal to RRk of the Xi′s=1,n− k of the Xi′s=0 
we show in the Appendix (section C) that, RERIn(X1, X2, … , Xn) for n≥2, is:  
RERIn(X1, X2, … , Xn) = RR(n) 
                                          − ∑ RR(n−1)
( nn−1)
 
                                         + ∑ RR(n−2)
( nn−2)
 
                                      ... 
                          +(−1)n ∗ ∑ RR(0)
(n0)
                                                (6)             
 
Of note that the last line can be written as (−1)n, once (n
0
) = 1 and RR(0) = 1.   
RERIn(X1, X2, … , Xn) in (6) expresses the relative excess risk due to interaction of the 
n risk factors exclusively, without accounting for all the lower order additive 
interactions of these risk factors [i.e. extension of (4)]. 
Additionally, by extending equation (4) in multi-way interaction, we additionally show 
in the Appendix (section C) that  RERIn can be written in terms of any 2 of the lower 
order (n-1) interactions, more specifically 
RERIn(X1, X2, … , Xn)
= (RERI𝑛−1(X1, X2, … , Xn|Xi = 1) ∗ RRX1−X2−…Xi+1−Xi+Xi+1−⋯Xi+1−⋯Xn−) 
                                     −RERI𝑛−1(X1, X2, … , Xn|Xi = 0)                                                       (7)          
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In Appendix (section D), we give the corresponding suggestions and recommendations 
for researchers who want to implement analysis for multi-way interactions in detail. 
Moreover, in Appendix (Section E), we show i) that multiplicative or super-
multiplicative effects imply super-additive effects and ii) that additive or sub-additive 
effects imply sub-multiplicative effects for n-way interactions as well. 
 
Worked Example 
To illustrate the formulae derived in the previous sections we have used data 
from adult women participating in the Greek-EPIC study[29-30] to study the joint 
effects of low adherence to Mediterranean Diet (MD), obesity and smoking status on 
mortality. We applied survival analysis with Cox regression using as endpoint death 
from any cause.  Levels of the indicated risk factors denoting potentially increased risk 
of death were i) low (scores 0-3 vs 4-9) adherence to MD, ii) obesity [Body Mass Index 
(BMI)≥30 kg/m2 vs <30 kg/m2], and (iii) smoking status (current vs. former and current) 
at recruitment. Age (in years) and education (4 levels; categorically modeled) were 
included as possible confounders. Participants with missing values in any of the above 
variables were excluded, leaving 15,903 women. Descriptive statistics of all variables 
included in the analysis are presented in table 1. In the Cox model, we included three 
terms for each risk factor, three terms for the 2-way product terms between those factors 
and one for the 3-way product term of all three factors.   
The respective TotRERI3, RERI3 between the indicated risk factors, as well as their 
components i.e all 2- and 3-way interactions have been estimated using equations 
(A.SB.2)-(A.SB.9) (see Appendix, Section B). The Stata code that was used can be 
found online on github (https://github.com/mkatsoulis82/Multi-
way_interaction/blob/master/Multi-way%20interaction.do ), as well as in Appendix 
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(Section B) For the estimation of 95% confidence intervals, we used the delta method. 
In Table 2, we present the mortality hazard ratios, of low adherence to MD, obesity 
and smoking and of their joint effects as estimated by Cox regression [model 
(A.SB.1) in the Appendix (section B)].   
 
RESULTS 
From Table 2, we conclude that the effects of low MD, obesity and smoking status on 
mortality were super-additive (TotRERI3=1.20, even not statistically significant), 
meaning that there was an extra 120% risk due to the joint presence of all risk factors, 
compared to the situation that each of them would act separately (see equation 1). 
More specifically, the 3-way interaction of these factors beyond the 2-way 
interactions was positive (RERI3=1.98), indicating that there was a ~200% excess risk 
which is explicitly due to the 3-way interaction. On the other hand, all the RERI2s 
given the absence of the 3rd risk factor are negative, even not statistically significant 
(first 3 rows in table 2 referring to RERIs), which is an indication that the relative risk 
from joint action of any two of the following: having low MD score, being a smoker 
and being obese, when the third factor is absent, is lower compared to sum of the 
relative risks of these risk factors, when acting separately (sub-additive effects). This 
means that the excess 120% risk due to the joint presence of all risk factors 
(TotRERI=1.20) is largely due to the 3-way interaction of the 3 risk factors itself 
(RERI3=1.98), as the contribution of the 2-way interactions is negative (see equation 
2). Moreover, the corresponding 2-way interactions are positive, when the third risk 
factor is present, which is reflected by the 3-way interaction that can be expressed in 
terms of the 2-way interactions [see (4)]. Finally, there was no qualitative interaction 
in this example. 
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DISCUSSION 
In this paper, we pointed out the questions of interest in the study of the joint 
action of >2 binary factors on a health outcome and we proposed the appropriate 
solutions, by introducing formulae for additive interaction. Previous publications on 
interactions on the additive scale refer almost exclusively to two-way interactions 
probably for reasons related to easiness in interpretability and communication of 
results.  
Given this gap in the relevant studies of multi-way interactions on the additive 
scale, our results are novel for epidemiological research that focuses on the joint action 
of >2 exposures. We introduced the term “total relative excess risk due to interaction 
(TotRERI)”, a quantity that encompasses all intermediate levels of interaction in the 
presence of three or more factors. Our formulae enable better interpretability of any 
evidence for deviations from additivity owned to more than two risk factors and provide 
simple ways of communicating such results from a public health perspective by 
attributing any excess relative risk to specific combinations of these factors. Regarding 
the limitations, researchers should also be concerned whether all possible categories 
defined by the absence and the presence of the n risk factors include sufficient number 
of participants, so that all RR’s from expressions (3), for 3 risk factors, or (6), for n risk 
factors, can be adequately estimated. For case-control studies our results apply for rare 
diseases only, taking into consideration certain limitations that have expressed in the 
relevant literature, when using logistic regression[12]. Finally, the problem of the 
limited power in calculating 2-way interactions[17] is also present in multi-way 
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interaction. As observed from our worked example, all the additive interactions were 
had very wide confidence intervals.  
 
CONCLUSIONS 
Given the increasing interest in investigating and evaluating interactions, our 
results are important for studying multi-way interactions between risk factors and 
identifying combinations the joint presence of which may be especially important to 
avoid from a public health perspective. 
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BMI: Body Mass Index 
ERR: Excess relative risk 
EPIC: European Prospective Investigation into Cancer and nutrition 
MD: Mediterranean Diet  
RERI: Relative excess risk due to interaction 
RR: Relative risk 
TotRERI: Total relative excess risk due to interaction 
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Table 1: Descriptive statistics of the characteristics of 15903 women participating in 
analysis 
CONTINUOUS VARIABLES 
 mean (sd) 
Age (in years) , mean (sd) 53.4 (12.5) 
CATEGORICAL VARIABLES 
 N (%) 
BMI  
   Obese (BMI>=30) 6206 (39%) 
   Non-Obese (BMI<30) 9697 (61%) 
Mediterranean diet  
   Low adherence (0-3) 5466 (34%) 
   Medium-High adherence  (4-9) 10437 (66%) 
Smoking status  
    Current smokers ,n(%) 3038 (19%) 
    Never-Former smokers ,n(%) 12865 (81%) 
Education  
    1st level: no education (<6 years of schooling) ,n(%) 4100 (26%) 
    2nd level: elementary/high school (6-11 years of 
schooling) ,n(%) 
6502 (41%) 
    3rd level: lyceum/technical lyceum (12 years of schooling) ,n(%) 2872 (18%) 
    4th level: at least university degree (>12 years of 
schooling) ,n(%) 
2429 (15%) 
Mortality  
    Alive till the end of follow-up 14699 (92%) 
    Dead during follow-up 1204 (8%) 
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Table 2: Estimated hazard ratios of Mediterranean Diet (MD), obesity and smoking and of their product terms from the Cox regression (A.SB.1) 
from the mortality analysis conducted in women from the EPIC-Greece cohort, along with indexes of additive interaction between low 
adherence to MD, obesity and smoking.  
Results from Cox regression* 
Risk factors of interest and their product terms b se(b) HR 95% CI for HR 
low MD 0.36 0.09 1.43 1.20 , 1.71 
high BMI  0.29 0.08 1.34 1.14 , 1.56 
never or former smokers 0.41 0.18 1.51 1.05 , 2.16 
(low MD)   * (high BMI) -0.27 0.12 0.77 0.60 , 0.97 
(low MD)   * (never or former smokers) -0.23 0.30 0.79 0.44 , 1.44 
(high BMI) * (never or former smokers) -0.24 0.29 0.79  0.45 , 1.40 
(low MD)   *  ( high BMI) *  (never or former smokers) 0.92 0.45 2.51 1.04 , 6.02 
Relative excess risk due to interaction (RERI) 
 RERI se(RERI) 95 % CI for RERI 
RERI2(low MD, high BMI / never or former smokers) -0.30 0.17 -0.64 , 0.03 
RERI2(low MD, current smokers / low BMI) -0.23 0.49 -1.19 , 0.74 
RERI2(high BMI, current smokers / high MD) -0.25 0.45 -1.13 , 0.63 
RERI2(low MD, high BMI / current smokers) 1.11 0.63 -0.12 , 2.35 
RERI2(low MD, current smokers / high BMI) 1.31 0.65 0.05 , 2.58 
RERI2(high BMI, current smokers / low MD) 1.20 0.62 -0.01 , 2.41 
RERI3(low MD, high BMI ,current smokers) 1.98 1.01 0.00 , 3.96 
TotRERI3(low MD, high BMI ,current smokers) 1.20 0.83 -0.43 , 2.82 
*In the Cox regression (model A.SB.1), we adjusted for age (in years) and educational levels (<6, 6-11, 12 and >12 years of schooling; 
categorically) 
APPENDIX 
 
 
Section A – Interaction between 3 risk factors 
 
We have that 
RERI2(X1, X2 |X3 = 0) = RRX1+X2+X3− − RRX1+X2−X3− − RRX1−X2+X3−+ RRX1−X2−X3−         (A.SA.1) 
RERI2(X1, X3 |X2 = 0) = RRX1+X2−X3+ − RRX1+X2−X3− − RRX1−X2−X3++ RRX1−X2−X3−         (A.SA.2) 
RERI2(X2, X3 |X1 = 0) = RRX1−X2+X3+ − RRX1−X2+X3− − RRX1−X2−X3++ RRX1−X2−X3−         (A.SA.3) 
So, by replacing in equation 2 (in the paper) to TotRERI3(X1, X2, X3),RERI2(X1, X2 |X3 = 0), 
RERI2(X1, X3 |X2 = 0) and RERI2(X2, X3 |X1 = 0) from equations (1) (in the paper), (A.SA.1), 
(A.SA.2), (A.SA.3) respectively, then  RERI3(X1, X2, X3) can be also written as a function of RRs 
as follows:  
RERI3(X1, X2, X3)  = RRX1+X2+X3+ 
                                      −RRX1+X2+X3− − RRX1+X2−X3+ − RRX1−X2+X3+ 
                                      +RRX1+X2−X3− + RRX1−X2+X3− + RRX1−X2−X3+ 
                                     −RRX1−X2−X3−                                                                                                                
as presented in expression 3 (in the paper) 
Moreover, we have that 
RERI2(X1, X2|X3 = 1) =
( RRX1+X2+X3+−RRX1+X2−X3+−RRX1−X2+X3++RRX1−X2−X3+)
RRX1−X2−X3+
          (A.SA.4) 
RERI2(X1, X3|X2 = 1) =
( RRX1+X2+X3+−RRX1+X2+X3−−RRX1−X2+X3++RRX1−X2+X3−)
RRX1−X2+X3−
          (A.SA.5) 
RERI2(X2, X3|Xl = 1) =
( RRX1+X2+X3+−RRX1+X2+X3−−RRX1+X2−X3++RRX1+X2−X3−)
RRX1+X2−X3−
           (A.SA.6) 
Of note, we standardize RERI2 when the 3
rd
 variable is present by the RR of the 3
rd
 variable, 
because in the analysis we conduct, all RR’s are calculated taking into consideration that 
RRX1−X2−X3− is the reference relative risk. However, in (A.SA.4), we are interested in  
 RRX1+X2+, given that X3 is present, compared to RRX1−X2−, given that X3 is present, so 
the relative risk of interest will be 
RRX1+X2+X3+
RRX1−X2−X3+
⁄  
 RRX1+X2−, given that X3 is present, compared to RRX1−X2−, given that X3 is present, so 
the relative risk of interest will be 
RRX1+X2−X3+
RRX1−X2−X3+
⁄  
 RRX1−X2+, given that X3 is present, compared to RRX1−X2−, given that X3 is present, so 
the relative risk of interest will be 
RRX1−X2+X3+
RRX1−X2−X3+
⁄  
 RRX1−X2−, given that X3 is present, compared to RRX1−X2−, given that X3 is present, so 
the relative risk of interest will be 
RRX1−X2−X3+
RRX1−X2−X3+
⁄  
By combining these bullets, it is straightforward why we standardize by  RRX1−X2−X3+ in 
(A.SA.4). For the same reasons we standardized by RRX1−X2+X3− and RRX1+X2−X3− in (A.SA.5) 
 and (A.SA.6). 
 
Moreover, it is also straightforward that if we combine (A.SA.1) and (A.SA.4), or (A.SA.2) and 
(A.SA.5), or (A.SA.3) and (A.SA.6), we end up to equation (4) in the manuscript. 
Section B – Estimation of interactions between 3 risk factors when using Cox (or logistic) 
regression and implementation in STATA 
 
Estimations using Cox regression  
We consider dichotomous variables X1, X2 and X3 as risk factors for the outcome of 
interest (disease D in incidence analysis or death in mortality analysis) with Xi=(0,1) referring to 
the absence/presence of risk factor Xi hypothesized to be associated with the lowest/highest risk 
for disease D). Let also Uj, j=1,2,...,n denote additional variables which serve as potential 
confounders to the association of Xi with D. Finally, let the hazard rate for disease D at time t be 
𝜆(𝑡) = 𝜆(𝑡, 𝑋1, 𝑋2, 𝑋3, 𝑍𝑗) as estimated from Cox regression model including X1, X2 and X3. and 
additional covariates X1X2,X1X3, X2X3 and X1X2X3 for all 2 and 3 way interactions of X1, X2 
and X3, and controlling for n covariates Uj, j=1,2,...,n :  
λ(t) = λ0(t) ∗ exp⁡(a1X1 + a2X2 + a3X3 + a4X1X2 + a5X1X3 + a6X2X3 + a7X1X2X3 + ∑ cjUj
n
j=1 ) ,    (A.SB.1) 
where ak, k=1,..,7 and cj, j=1,..,N  are the log of the hazard ratios estimated from the Cox model. 
Based on model (A.SB.1), TotRERI3(X1,X2,X3) and  RERI3 (X1, X2, X3) can be estimated as 
shown below: 
TotRERI3(X1, X2, X3) = RRX1+X2+X3+ − RRX1+X2−X3− − RRX1−X2+X3− − RRX1−X2−X3+ + 2⁡⁡ 
⁡⁡⁡= exp(a1 + a2 + a3 + a4 + a5 + a6 + a7) − exp(a1) − exp(a2) − exp(a3) + 2                (A.SB.2)     
and 
RERI3(X1, X2, X3) = RRX1+X2+X3+ − RRX1+X2+X3− − RRX1+X2−X3+ − RRX1−X2+X3+ 
⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡+RRX1+X2−X3−+RRX1−X2+X3−+RRX1−X2−X3+ − RRX1−X2−X3− 
         = exp(a1 + a2 + a3 + a4 + a5 + a6 + a7) − exp(a1 + a2 + a4) − exp(a1 + a3 + a5) 
⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡−exp(a2 + a3 + a6) + exp(a1) + exp(a2) + exp(a3) − 1                         (A.SB.3) 
Similarly, one can estimate also the components of TotRERI3(X1,X2,X3) and RERI3(X1, X2, X3), 
based on  (A.SB.1): 
RERI2(X1, X2|X3 = 0) = ⁡exp(a1 + a2 + a4) − exp(a1) − exp(a2) + 1                    (A.SB.4)  
RERI2(X1, X3|X2 = 0) = ⁡exp(a1 + a3 + a5) − exp(a1) − exp(a3) + 1                    (A.SB.5) 
RERI2(X2, X3|X1 = 0) = ⁡exp(a2 + a3 + a6) − exp(a2) − exp(a3) + 1                    (A.SB.6) 
RERI2(X1 , X2|X3 = 1) =
exp(a1+a2+a3+a4+a5+a6+a7)−exp(a1+a3+a5)−exp(a2+a3+a6)+exp(a3)⁡⁡⁡
exp(a3)
        (A.SB.7) 
RERI2(X1 , X3|X2 = 1) =
exp(a1+a2+a3+a4+a5+a6+a7)−exp(a1+a2+a4)−exp(a2+a3+a6)+exp(a2)⁡⁡⁡
exp(a2)
        (A.SB.8)     
RERI2(X2 , X3|X1 = 1) =
exp(a1+a2+a3+a4+a5+a6+a7)−exp(a1+a2+a4)−exp(a1+a3+a5)+exp(a1)⁡⁡⁡
exp(a1)
        (A.SB.9)     
 
Implementation in STATA 
/* 
DESCRIPTION 
time; survival time 
death (outcome); 0-->alive, 1-->dead 
x1 (non adherence to Mediterranean diet - 1st risk factor);  
0--> high adherence to Mediterranean diet, 1--> low adherence to Mediterranean diet 
 
x2 (being obese - 2nd risk factor);  
0--> not being obese (BMI<30), 1--> being obese (BMI>=30) 
 
x3 (smoking status - 3rd risk factor);  
0--> never/former smoker, 1--> current smoker 
 u1 (age             - 1st confounder); continuous in years 
u2 (education level - 2nd confounder); categorical in 4 levels 
*/ 
 
* IMPLEMENTATION 
* At first we compute the product terms 
gen x1x2=x1*x2 
gen x1x3=x1*x3 
gen x2x3=x2*x3 
gen x1x2x3=x1*x2*x3 
 
*We run the Cox model 
stset time, failure(death) 
 
stcox x1 x2 x3 x1x2 x1x3 x2x3 x1x2x3 u1 i.u2 
 
 
*We compute TotRERI3 
nlcom TotRERI3: exp(_b[x1]+_b[x2]+_b[x3]+_b[x1x2]+_b[x1x3]+_b[x2x3]+_b[x1x2x3])-
exp(_b[x1])-exp(_b[x2])-exp(_b[x3])+2 
 
*We compute RERI3 
nlcom RERI3:    exp(_b[x1]+_b[x2]+_b[x3]+_b[x1x2]+_b[x1x3]+_b[x2x3]+_b[x1x2x3])-
exp(_b[x1]+_b[x2]+_b[x1x2])-exp(_b[x1]+_b[x3]+_b[x1x3])-
exp(_b[x2]+_b[x3]+_b[x2x3])+exp(_b[x1])+exp(_b[x2])+exp(_b[x3])-1 
 *We compute 2-way interactions, given the 3rd risk factor is absent 
*RERI(x1,x2/x3=0) 
nlcom RERI2_x1_x2_given_x3is0: exp(_b[x1]+_b[x2]+_b[x1x2])-exp(_b[x1])-exp(_b[x2])+1 
*RERI(x1,x3/x2=0) 
nlcom RERI2_x1_x3_given_x2is0: exp(_b[x1]+_b[x3]+_b[x1x3])-exp(_b[x1])-exp(_b[x3])+1 
*RERI(x2,x3/x1=0) 
nlcom RERI2_x2_x3_given_x1is0: exp(_b[x2]+_b[x3]+_b[x2x3])-exp(_b[x2])-exp(_b[x3])+1 
 
*We compute 2-way interactions, given the 3rd risk factor is present 
 
*RERI(x1,x2/x3=1) 
nlcom RERI2_x1_x2_given_x3is1: 
(exp(_b[x1]+_b[x2]+_b[x3]+_b[x1x2]+_b[x1x3]+_b[x2x3]+_b[x1x2x3])-
exp(_b[x1]+_b[x3]+_b[x1x3])-exp(_b[x2]+_b[x3]+_b[x2x3])+exp(_b[x3]))/exp(_b[x3]) 
 
*RERI(x1,x3/x2=1) 
nlcom RERI2_x1_x3_given_x2is1: 
(exp(_b[x1]+_b[x2]+_b[x3]+_b[x1x2]+_b[x1x3]+_b[x2x3]+_b[x1x2x3])-
exp(_b[x1]+_b[x2]+_b[x1x2])-exp(_b[x2]+_b[x3]+_b[x2x3])+exp(_b[x2]))/exp(_b[x2]) 
 
*RERI(x2,x3/x1=1) 
nlcom RERI2_x2_x3_given_x1is1: 
(exp(_b[x1]+_b[x2]+_b[x3]+_b[x1x2]+_b[x1x3]+_b[x2x3]+_b[x1x2x3])-
exp(_b[x1]+_b[x2]+_b[x1x2])-exp(_b[x1]+_b[x3]+_b[x1x3])+exp(_b[x1]))/exp(_b[x1]) 
 
*The same formulae for all these RERIs are used when running logistic regression 
* CHECK FOR QUALITATIVE INTERACTION 
 
*We run again the Cox model 
stset time, failure(death) 
 
stcox x1 x2 x3 x1x2 x1x3 x2x3 x1x2x3 u1 i.u2 
 
* To check whether the risk for x1 is increasing across strata of x2,x3, we have to examine 
whether the following quantities are positive (i.e. >0) 
* 1a) to see if RR100>RR000, we check whether RR100-RR000>0 
disp exp(_b[x1])-1 
* 1b) to see if RR110>RR010, we check whether RR110-RR010>0 
disp exp(_b[x1]+_b[x2]+_b[x1x2])-exp(_b[x2]) 
* 1c) to see if RR101>RR001, we check whether RR101-RR001>0 
disp exp(_b[x1]+_b[x3]+_b[x1x3])-exp(_b[x3]) 
* 1d) to see if RR111>RR011, we check whether RR111-RR011>0 
disp exp(_b[x1]+_b[x2]+_b[x3]+_b[x1x2]+_b[x1x3]+_b[x2x3]+_b[x1x2x3])-
exp(_b[x2]+_b[x3]+_b[x2x3]) 
 
 
* To check whether the risk for x2 is increasing across strata of x1,x3 
* 2a) to see if RR010>RR000, we check whether RR010-RR000>0 
disp exp(_b[x2])-1 
* 2b) to see if RR110>RR100, we check whether RR110-RR100>0 
disp exp(_b[x1]+_b[x2]+_b[x1x2])-exp(_b[x1]) 
* 2c) to see if RR011>RR001, we check whether RR011-RR001>0 
disp exp(_b[x2]+_b[x3]+_b[x2x3])-exp(_b[x3]) 
* 2d) to see if RR111>RR101, we check whether RR111-RR101>0 
disp exp(_b[x1]+_b[x2]+_b[x3]+_b[x1x2]+_b[x1x3]+_b[x2x3]+_b[x1x2x3])-
exp(_b[x1]+_b[x3]+_b[x1x3]) 
 
 
* To check whether the risk for x3 is increasing across strata of x1,x2 
* 2a) to see if RR001>RR000, we check whether RR001-RR000>0 
disp exp(_b[x3])-1 
* 2b) to see if RR101>RR100, we check whether RR101-RR010>0 
disp exp(_b[x1]+_b[x3]+_b[x1x3])-exp(_b[x1]) 
* 2c) to see if RR011>RR010, we check whether RR011-RR100>0 
disp exp(_b[x2]+_b[x3]+_b[x2x3])-exp(_b[x2]) 
* 2d) to see if RR111>RR110, we check whether RR111-RR110>0 
disp exp(_b[x1]+_b[x2]+_b[x3]+_b[x1x2]+_b[x1x3]+_b[x2x3]+_b[x1x2x3])-
exp(_b[x1]+_b[x2]+_b[x1x2]) 
 
 
Section C – proofs of equations of multi way interaction 
Proof of expression (6) 
We define the excess relative risk by ERRX1#X2#…Xn# , where # = +/-, as 
ERRX1#X2#…Xn# = RRX1#X2#…Xn# − RRX1−X2−⋯Xn−                 , i.e.  
ERRX1#X2#…Xn# = RRX1#X2#…Xn# − 1 
Now, expression (5) from the text can be written as 
TotRERIn(X1, X2, … , Xn) =  ERRX1+X2+⋯Xn+   
                                −ERRX1+X2−⋯Xn− − ERRX1−X2+⋯Xn− − ⋯ − ERRX1−X2−⋯Xn+         (A.SC.1) 
TotRERIn can be expressed in terms of relative risks (see equation 5 in the paper), but also as a function of all interactions, more specifically all 
RERIk for k≤n, that is 
TotRERIn(X1, X2, … , Xn) = RERIn(X1, X2, … , Xn) 
                                                +  ∑ RERIn−1(X1, X2, … , Xn|1 of the Xi = 0)
( nn−1)
 
                                                +  ∑ RERIn−2(X1, X2, … , Xn|2 of the Xi = 0)
( nn−2)
 
                                                   ... 
                                                +  ∑ RERI2(X1, X2, … , Xn|(n − 2) of the Xi = 0)
(n2)
                               (A. SC. 2) 
Now, to calculate RERIn, we can combine equations (A.SC.1) and (A.SC.2), we have to solve the recurrence relation 
RERIn + ∑ RERIn−1
( nn−1)
+ ∑ RERIn−2
( nn−2)
+ ⋯ + ∑ RERI2
(n2)
=  ERRX1+X2+⋯Xn+ − ERRX1+X2−⋯Xn− − ERRX1−X2+⋯Xn− − ⋯ − ERRX1−X2−⋯Xn+ 
Where RERIn−k = RERIk(X1, X2, … , Xn|(n − k) of the Xi = 0) 
In other words, we have to solve 
RERIn =  ERRX1+X2+⋯Xn+ − ERRX1+X2−⋯Xn− − ERRX1−X2+⋯Xn− − ⋯ − ERRX1−X2−⋯Xn+ − ∑ RERIn−1
(n1)
− ∑ RERIn−2
(n2)
− ⋯ − ∑ RERI2
( nn−2)
 
using as notation RR(k) = RRk of the n Xi
′s=1,the rest (n−k)  Xi
′s=0  we have that 
RERIn =  RR(n) − RR(0) − ∑ ERR(1)
(n1)
− ∑ RERIn−1
( nn−1)
− ∑ RERIn−2
( nn−2)
− ⋯ − ∑ RERI2
(n2)
 
in other words 
RERIn =  RR(n) − ∑ RERIn−1
( nn−1)
− ∑ RERIn−2
( nn−2)
− ⋯ − ∑ RERI2
(n2)
− ∑ ERR(1)
(n1)
− ∑ RR(0)
(n0)
                                         (A. SC. 3) 
when we express all the (different)  RERIn−1’s from the recurrence relation (A.SC.3), we have that 
RERIn =  RR(n) − ∑ RR(n−1)
( nn−1)
+ ∑ ∑ RERIn−2
(n−1n−2)(
n
n−1)
+ ∑ ∑ RERIn−3
(n−1n−3)
+ ⋯ + ∑ ∑ RERIn−k
(n−1n−k)(
n
n−1)(
n
n−1)
+ ⋯ + ∑ ∑ ERR1
(n−11 )(
n
n−1)
+ ∑ ∑ RR0
(n−10 )(
n
n−1)
 
                                                                       − ∑ RERIn−2
( nn−2)
− ∑ RERIn−3
( nn−3)
        − …          − ∑ RERIn−k
(nk)
−       …      − ∑ ERR1
(n1)
− ∑ RR0
(n0)
         (A. SC. 4) 
and when we express all RERIn−2’s from (A.SC.4) using the recurrence relation (A.SC.3), we have that 
RERIn =  RR(n) − ∑ RR(n−1)
( nn−1)
+ ( ∑ ∑ RR(n−2) −
(n−1n−2)(
n
n−1)
∑ RR(n−2)
( nn−2)
) 
                     − ∑ ∑ ∑ RERIn−3
(n−2n−3)(
n−1
n−2)
− ∑ ∑ ∑ RERIn−4
(n−2n−4)(
n−1
n−2)(
n
n−1)
− ⋯ − ∑ ∑ ∑ RERIn−k
(n−2n−k)(
n−1
n−2)(
n
n−1)(
n
n−1)
− ⋯ − ∑ ∑ ∑ RR0
(n−20 )(
n−1
n−2)(
n
n−1)
 
                               + ∑ ∑ RERIn−3
(n−1n−3)
+         ∑ ∑ RERIn−4
(n−1n−4)
+
( nn−1)
…         + ∑ ∑ RERIn−k
(n−1n−k)(
n
n−1)(
n
n−1)
+      …     + ∑ ∑ RR0
(n−10 )(
n
n−1)
 
                               + ∑ ∑ RERIn−3
(n−2n−3)
+         ∑ ∑ RERIn−4
(n−2n−4)
+
( nn−2)
…         + ∑ ∑ RERIn−k
(n−2n−k)(
n
n−2)(
n
n−2)
+      …     + ∑ ∑ RR0
(n−20 )(
n
n−2)
 
                                         − ∑ RERIn−3
( nn−3)
       −            ∑ RERIn−4
( nn−4)
−      …               − ∑ RERIn−k
(nk)
 −    …                      − ∑ RR0
(n0)
                  (A. SC. 5) 
of interest from (A.SC.5) to compute the quantity 
∑ ∑ RR(n−2) −
(n−1n−2)(
n
n−1)
∑ RR(n−2)
( nn−2)
                              (A. SC. 6) 
i.e. how many time we are going to sum up RR(n−2) 
from combinatorics, it is known that  
(
n
r
) (
r
k
) = (
n
k
) (
n − k
r − k
) 
so from (A.SC.6) we have that  
(
n
n − 1
) (
n − 1
n − 2
) = (
n
n − 2
) (
n − n + 2
n − 1 − n + 2
) = (
n
n − 2
) (
2
1
) = 2 (
n
n − 2
) 
in other words, ( n
n−1
)(n−1
n−2
) − ( n
n−2
) = 2( n
n−2
) − ( n
n−2
) = ( n
n−2
) 
so it seems that 
∑ ∑ RR(n−2) −
(n−1n−2)
( nn−1)
∑ RR(n−2)
( nn−2)
= ∑ RR(n−2)
( nn−2)
                                   (A. SC. 7) 
However, to prove (A.SC.7) and more specifically that the summation of RR(n−2) will be the sum of all different RR(n−2)’s, we work as follows;   
It is obvious that the part of the summation of RR(n−2) , which is created through the route 
 RERIn → RERIn−2 is equal to 
∑ RR(n−2)
( nn−2)
 
more specifically it is equal the sum of all different RR(n−2)’s 
Now, we have to prove that the part of the summation of RR(n−2) , which is created through the route  
RERIn → RERIn−1 → RERIn−2, which is 
∑ ∑ RR(n−2)
(n−1n−2)(
n
n−1)
 
can be written 
∑ ∑ RR(n−2)
(n−1n−2)(
n
n−1)
= 2 ∗ ∑ RR(n−2)
( nn−2)
 
In other words, that is equal to the sum of the ( n
n−2
) different RERIn−2, multiplied by 2 
To show that, we work as follows; 
We have ( n
n−1
) = 𝑛 different RERIn−1’s that lead to (
n
n−1
)(n−1
n−2
) = 2 ∗ ( n
n−2
) = 2 ∗
(𝑛−1)(𝑛−2)
2
     RERIn−2’s       
i.e. (𝑛 − 1)(𝑛 − 2) RERIn−2’s through the following pattern 
 
                               RERIn−1|𝑋1 −                                                    
( nn−1) = 𝑛            RERIn−1|𝑋2 −                                    RERIn−2|𝑋1−, 𝑋2 −            (
n−1
n−2) = 𝑛 − 1 
different                                                                             RERIn−2|𝑋1−, 𝑋3 −      different  RERIn−2’s 
RERIn−1’s                   …                                                                   …                       created by RERIn−1|𝑋1 −         
                                RERIn−1|𝑋𝑛 −                                   RERIn−2|𝑋1−, 𝑋𝑛 − 
                                                                                            RERIn−2|𝑋2−, 𝑋1 −            (
n−1
n−2) = 𝑛 − 1 
                                                                                            RERIn−2|𝑋2−, 𝑋3 −      different  RERIn−2’s 
                                                                                                         …                          created by RERIn−1|𝑋2 −         
                                                                                            RERIn−2|𝑋2−, 𝑋𝑛 − 
                                                                                             …     …     …                  
                                                                                            RERIn−2|𝑋𝑛−, 𝑋1 −            (
n−1
n−2) = 𝑛 − 1 
                                                                                            RERIn−2|𝑋𝑛−, 𝑋2 −        different  RERIn−2’s 
                                                                                                         …                            created by RERIn−1|𝑋𝑛 −         
                                                                                            RERIn−2|𝑋𝑛−, 𝑋𝑛−1 − 
From above, we can observe that the ( n
n−2
) different RERIn−2 are created from the  (
n
n−1
) = 𝑛 different RERIn−1’s twice. This is done because 
RERIn−2|𝑋𝑚−, 𝑋𝑙 − is derived by both RERIn−1|𝑋𝑚 − and RERIn−1|𝑋𝑙 −, but from no other RERIn−1|𝑋𝑗 −, j≠m, j≠l (for example see 
RERIn−2|𝑋1−, 𝑋2 − and RERIn−2|𝑋1−, 𝑋𝑛 −). So the total RR(n−2) that will be created through the route RERIn → RERIn−1 → RERIn−2 is equal 
to  
∑ ∑ RR(n−2)
(n−1n−2)(
n
n−1)
= 2 ∗ ∑ RR(n−2)
( nn−2)
 
After this result, (A.SC.7) is proved, because 
∑ ∑ RR(n−2) −
(n−1n−2)(
n
n−1)
∑ RR(n−2)
( nn−2)
= 2 ∗ ∑ RR(n−2)
( nn−2)
− ∑ RR(n−2)
( nn−2)
= ∑ RR(n−2)
( nn−2)
 
 
Furthermore, when we express RERIn−3 from (A.SC.5) using the recurrence relation (A.SC.3), we have that 
RERIn =  RR(n) − ∑ RR(n−1)
( nn−1)
+ ∑ RR(n−2)
( nn−2)
− ( ∑ ∑ ∑ RR(n−3) −
(n−2n−3)(
n−1
n−2)(
n
n−1)
∑ ∑ RR(n−3) −
(n−1n−3)
∑ ∑ RR(n−3) +
(n−2n−3)(
n
n−2)(
n
n−1)
∑ RR(n−3)
( nn−3)
) 
          + ∑ ∑ ∑ ∑ RERIn−4
(n−3n−4)(
n−2
n−3)(
n−1
n−2)
+ ∑ ∑ ∑ ∑ RERIn−5
(n−3n−5)(
n−2
n−3)(
n−1
n−2)(
n
n−1)
+ ⋯ + ∑ ∑ ∑ ∑ RERIn−k
(n−3n−k)(
n−2
n−3)(
n−1
n−2)(
n
n−1)(
n
n−1)
+ ⋯ + ∑ ∑ ∑ ∑ RR0
(n−30 )(
n−2
n−3)(
n−1
n−2)(
n
n−1)
 
                               …                                      …                        …                      …                             … 
                               …                                      …                        …                      …                             … 
                               …                                      …                        …                      …                             … 
                                         − ∑ RERIn−4
( nn−4)
       −            ∑ RERIn−5
( nn−5)
−          …               − ∑ RERIn−k
(nk)
                            − ∑ RR0
(n0)
                (A. SC. 8) 
 
of interest from (A.SC.8) to compute how many time we are going to sum up RR(n−3), i.e. 
∑ ∑ ∑ RR(n−3) −
(n−2n−3)(
n−1
n−2)
( nn−1)
∑ ∑ RR(n−3) −
(n−1n−3)
∑ ∑ RR(n−3) +
(n−2n−3)
( nn−2)(
n
n−1)
∑ RR(n−3)
( nn−3)
                              (A. SC. 9) 
 
We have that 
(
n
n − 1
) (
n − 1
n − 2
) (
n − 2
n − 3
) = 6 (
n
n − 3
) , (
n
n − 1
) (
n − 1
n − 3
) = 3 (
n
n − 3
) , (
n
n − 2
) (
n − 2
n − 3
) = 3 (
n
n − 3
) , 𝑠𝑜 
6 (
n
n − 3
) − 3 (
n
n − 3
) − 3 (
n
n − 3
) + (
n
n − 3
) = (
n
n − 3
) 
 
so if we work as we did to show (A.SC.7), we will find that 
( ∑ ∑ ∑ RR(n−3) −
(n−2n−3)(
n−1
n−2)
( nn−1)
∑ ∑ RR(n−3) −
(n−1n−3)
∑ ∑ RR(n−3) +
(n−2n−3)
( nn−2)(
n
n−1)
∑ RR(n−3)
( nn−3)
) = ∑ RR(n−3)
( nn−3)
 
 
In other words, (A.SC.9) is equal to the sum of the ( n
n−3
) different RR(n−3), that come from the application of (A.SC.3) for the conversion of 
( n
n−3
) different RERI(n−3)’s. 
 
Moreover, for the parenthesis related to the summation of RR(n−3) (i.e. (A.SC.9) we may also calculate it as follows: 
We let  
∑ ∑ ∑ RR(n−3)(n−2n−3)(
n−1
n−2)
( nn−1)
→ (1   2)RR(n−3), i.e. the part of the summation that RR(n−3) is calculated from RERIn−3through the route 
                                                                    RERIn → RERIn−1 → RERIn−2 → RERIn−3 (we name points [1] and [2]),  
                                                                    i.e. we go from RERInto RERIn−3through RERIn−1to RERIn−2 (points [1] and [2] respectively) 
∑ ∑ RR(n−3)(n−1n−3)(
n
n−1)
           → (1)RR(n−3),      i.e. the part of the summation that RR(n−3) is calculated from RERIn−3through the route 
                                                                    RERIn → RERIn−1 → RERIn−3 (we name point [1]),  
∑ ∑ RR(n−3)(n−2n−3)(
n
n−2)
           → (2)RR(n−3),      i.e. the part of the summation that RR(n−3) is calculated from RERIn−3through the route 
                                                                    RERIn → RERIn−2 → RERIn−3 (we name point [2]),  
∑ RR(n−3)( nn−3)
                      → (Ø)RR(n−3),      i.e. the part of the summation that RR(n−3) is calculated from RERIn−3through the direct route 
                                                                    RERIn → RERIn−3 (we name no point [Ø]),  
 
We also name the summation {1   2}RR(n−3)  as follows 
{1   2}RR(n−3) = (1   2)RR(n−3) − (1)RR(n−3) − (2)RR(n−3) + (Ø)RR(n−3) = ∑ ∑ ∑ RR(n−3) −
(n−2n−3)(
n−1
n−2)
( nn−1)
∑ ∑ RR(n−3) −
(n−1n−3)
∑ ∑ RR(n−3) +
(n−2n−3)
( nn−2)(
n
n−1)
∑ RR(n−3)
( nn−3)
 
On the same way we have that {1}RR(n−2) = (1)RR(n−2) − (Ø)RR(n−2) , because {1}RR(n−2) = ∑ ∑ RR(n−2)(n−1n−2)(
n
n−1)
− ∑ RR(n−2)( nn−2)
 
All routes of {1}RR(n−2) are multiples of (
n
n−2
), i.e. because of (A.SC.7) we have  
(1)RR(n−2) = sum of (
n
n−2
) 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑡 RR(n−2), multiplied by b1, where b1 = 2   
(Ø)RR(n−2) = sum of (
n
n−2
) 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑡 RR(n−2) , multiplied by b2, where b2 = 1   
And on the same way, for {1   2}RR(n−3) , all routes of {1   2}RR(n−3)are multiples of (
n
n−3
) 
(1   2)RR(n−3) = sum of (
n
n−3
) 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑡 RR(n−3), multiplied by c1, where c1 = 6   
(1)RR(n−3) = sum of (
n
n−3
) 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑡 RR(n−3), multiplied by c2, where c2 = 3   
(2)RR(n−3) = sum of (
n
n−3
) 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑡 RR(n−3), multiplied by c3, where c3 = 3   
(Ø)RR(n−3) = sum of (
n
n−3
) 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑡 RR(n−3), multiplied by c4, where c4 = 1   
 
We further observe that the summation {1   2}RR(n−3) has q=2 points and  2
q
=2
2
=4 routes and are constructed as follows 
a) half of the  {1   2}RR(n−3)  routes (=2
2-1
 =2 routes) have point [2] as last point. This means that  
half of the  {1   2}RR(n−3)  routes (=2
2-1
 =2 routes) are made by the  {1}RR(n−2)  route after adding point [2] by summing up all ∑ RR(n−3)(n−2n−3)
, i.e. 
               (1   2)RR(n−3) , i. e. RERIn → RERIn−1 → RERIn−2 → RERIn−3  ∑ ∑ ∑ RR(n−3)(n−2n−3)(
n−1
n−2)
( nn−1)
             (A.SC.10) 
and         (2)RR(n−3)       i. e. = RERIn → RERIn−2 → RERIn−3  ∑ ∑ RR(n−3)(n−2n−3)(
n
n−2)
                       (A.SC.11) 
We name {1   2}RR(n−3);[i] the routes of {1   2}RR(n−3)  having as last point [i], where i=0,1 or 2.  
In other words, we name {1   2}RR(n−3);[i] all the routes RERIn → ⋯ → RERIn−i → RERIn−3 
For i=2 we find that 
since {1}RR(n−2) = ∑ RR(n−2)( nn−2)
, and we have that {1   2}RR(n−3);[2] = ∑ ∑ RR(n−3)(n−2n−3)(
n
n−2)
= (3
1
) ∗ ∑ RR(n−3)( nn−3)
 
{1   2}RR(n−3);[2] = ∑ ∑ ∑ RR(n−3) −
(n−2n−3)(
n−1
n−2)(
n
n−1)
∑ ∑ RR(n−3)
(n−2n−3)(
n
n−2)
= ∑ ∑ ∑ RR(n−3) −
(n−2n−3)(
n−1
n−2)(
n
n−1)
∑ ∑ RR(n−3)
(n−2n−3)(
n
n−2)
= 
But due to (A.SC.7), we have that 
= 2 ∗ ∑ ∑ RR(n−3)
(n−2n−3)
( nn−2)
− ∑ ∑ RR(n−3)
(n−2n−3)
( nn−2)
= ∑ ∑ RR(n−3)
(n−2n−3)
( nn−2)
 
b) 2
2-2
 =1 route of  {1   2}RR(n−3) is constructed having as last point [1], i.e. {1   2}RR(n−3);[1] 
                           {1   2}RR(n−3);[1] = (1)RR(n−3) , i. e. RERIn → RERIn−1 → RERIn−3  ∑ ∑ RR(n−3)(n−1n−3)(
n
n−1)
             (A.SC.12) 
Since {Ø}RR(n−1) = ∑ RR(n−1)( nn−1)
, we have that {1   2}RR(n−3);[1] = ∑ ∑ RR(n−3)(n−1n−3)(
n
n−1)
= (3
1
) ∗ ∑ RR(n−3)( nn−3)
 
c) 1 more route of {1   2}RR(n−3)  is constructed having as last point [0], i.e. {1   2}RR(n−3);[1] 
                           {1   2}RR(n−3);[0] = (Ø)RR(n−3)i. e. RERIn → RERIn−1 → RERIn−3∑ RR(n−3)( nn−3) ,                 (A.SC.13) 
 
So we have that 
{1   2}RR(n−3) = ∑(−1)
(𝑗−1) ∑ ∑ RR(n−3)
(n−
(3−j)
n−3 )(
n
n−(3−j))
3
𝑗=1
                                                                  (A. SC. 14) 
Now, we are ready to solve (A.SC.3), by applying complete induction to show that the summation of all RR(n−k) , for all k=1,2,...n when we 
replace all RERI(n) up to RERI(n−k)  in (A.SC.3) is ∑ RR(n−k)( nn−k)
 
In order to prove that, we apply step by step complete induction 
1) for i=1, the summation for RR(n−1) in (A.SC.3) is (see (A.SC.4)) 
∑ RR(n−1)
( nn−1)
 
i.e. our hypothesis hold 
2) for all i=2,3,...k-1, the summation for RR(n−i) in (A.SC.3) is  
∑ RR(n−i)
( nn−i)
 
3) for i=k, we have to show that the summation for RR(n−k) when we replace all RERI(n) up to RERI(n−k) in (A.SC.3) is 
∑ RR(n−k)( nn−k)
                                               (A.SC.15) 
To prove (A.SC.15), we have to show that 
{1   2   3  …  (𝑘 − 2)    (𝑘 − 1)}RR(n−k);[i] = ∑ ∑ RR(n−k)
( n−in−k)
( nn−i)
= (
k
i
) ∗ ∑ RR(n−k)
( nn−k)
                        (A. SC. 16) 
In other words, from (A.SC.16), we have all the different RR(n−k) appear (
k
i
) times from the routes of 
{1   2   3  …  (𝑘 − 2)    (𝑘 − 1)}RR(n−k)  having as last point [i], i.e. through all the routes  RERIn → ⋯ → RERIn−i → RERIn−k 
To prove (A.SC.16), we have to show that from the total  ∑ RR(n−i)( nn−i)
 of all different RR(n−i) , we end up to (
k
i
) ∗ ∑ RR(n−k)( nn−k)
 
different RR(n−k). 
We have that 
( nn−i)                      RERIn−i|𝑋1−, 𝑋2−, … , 𝑋𝑖−1−, 𝑋𝑖 −                                                     
different                RERIn−i|𝑋2−, 𝑋3−, … , 𝑋𝑖−, 𝑋𝑖+1 −                           RERIn−k|𝑋1−, 𝑋2−, … , 𝑋𝑖−, … , 𝑋𝑘−1−, 𝑋𝑘 −                            (
n−i
n−k) different  RERIn−k’s 
RERIn−i’s                 …                                                                              RERIn−k|𝑋1−, 𝑋2−, … , 𝑋𝑖−, … , 𝑋𝑘−2−, 𝑋𝑘−1−, 𝑋𝑘+1 −              created by 
                                                                                                                                            …                                                                          RERIn−i|𝑋1−, 𝑋2−, … , 𝑋𝑖−1−, 𝑋𝑖 − 
                                 
                                                                                                                       RERIn−k|𝑋1−, 𝑋2−, … , 𝑋𝑖−, … , 𝑋𝑘−1−, 𝑋𝑘 −                              (
n−i
n−k) different  RERIn−k’s   
                                                                                                                       RERIn−k|𝑋1−, 𝑋2−, … , 𝑋𝑖−, … , 𝑋𝑘−2−, 𝑋𝑘−1−, 𝑋𝑘+1 −                created by 
                                                                                                                                                                …                                                          RERIn−i|𝑋2−, 𝑋3−, … , 𝑋𝑖−, 𝑋𝑖+1 −         
From above, we can observe that all the ( n
n−k
) different RERIn−k are created from all the  (
n
n−i
) different RERIn−i’s (
k
i
) times. This is done 
because, for p∈P={1,.2,…,k}, RERIn−k|𝑋1 −, 𝑋2−, … , 𝑋𝑝−, … , 𝑋𝑘 − is derived by all RERIn−i|𝑖 𝑜𝑓 𝑡ℎ𝑒 𝑋𝑘 = 0, with i≤k, or in other words, 
i∈I⊂P,  but from no other RERIn−i|𝑎𝑛𝑦 𝑋𝑞 −, for q∉ P={1,.2,…,k}. The number of sets of I‘s , for which I⊂P is (
k
i
). So the total RR(n−k) that 
will be created through the route RERIn → ⋯ → RERIn−i → ⋯ → RERIn−k  is equal to ∑ ∑ RR(n−k)( n−in−k)(
n
n−i)
= (k
i
) ∗ ∑ RR(n−k)( nn−k)
. So 
(A.SC.16) holds. 
 
Now, using (A.SC.16), we have that  
{1   2   3  …  (𝑘 − 2)    (𝑘 − 1)}RR(n−k)  is constructed by  
{1   2   3  …  (𝑘 − 2)    (𝑘 − 1)}RR(n−k);[k−1] = ∑ ∑ RR(n−k)
(
n−(k−1)
n−k
)( nn−(k−1))
= ∑ ∑ RR(n−k)
(n−k+1n−k )
( nn−k+1)
= (
k
k − 1
) ∑ RR(n−k)
( nn−k)
 
{1   2   3  …  (𝑘 − 2)    (𝑘 − 1)}RR(n−k);[k−2] = ∑ ∑ RR(n−k)
(
n−(k−2)
n−k
)( nn−(k−2))
= ∑ ∑ RR(n−k)
(n−k+2n−k )
( nn−k+2)
= (
k
k − 2
) ∑ RR(n−k)
( nn−k)
 
...  
{1   2   3  …  (𝑘 − 2)    (𝑘 − 1)}RR(n−k);[1] = ∑ ∑ RR(n−k)
(
n−(k−(k−1))
n−k
)( nn−(k−(k−1)))
= ∑ ∑ RR(n−k)
(n−1n−k)(
n
n−1)
= (
k
1
) ∑ RR(n−k)
( nn−k)
 
{1   2   3  …  (𝑘 − 2)    (𝑘 − 1)}RR(n−k);[Ø] = ∑ ∑ RR(n−k)
(
n−(k−(k))
n−k
)( nn−(k−(k)))
= ∑ ∑ RR(n−k)
( nn−k)(
n
n)
= (
k
0
) ∑ RR(n−k)
( nn−k)
 
and as we can see from (A.SC.13), in a way that 
{1   2   3  …  (𝑘 − 2)    (𝑘 − 1)}RR(n−k) = {1   2   3  …  (𝑘 − 2)    (𝑘 − 1)}RR(n−k);[k−1]                                                                    
                                                                         −{1   2   3  …  (𝑘 − 2)    (𝑘 − 1)}RR(n−k);[k−2] 
                                                                         +{1   2   3  …  (𝑘 − 2)    (𝑘 − 1)}RR(n−k);[k−3] 
                                                                           … 
                                                                          ±{1   2   3  …  (𝑘 − 2)    (𝑘 − 1)}RR(n−k);[Ø]                                         (A.SC.17) 
So extending (A.SC.14), we have that 
{1   2   3  …  (𝑘 − 2)    (𝑘 − 1)}RR(n−k) = ∑(−1)
(𝑗−1) ∑ ∑ RR(n−k)
(
n−(k−j)
n−k
)( nn−(k−j))
𝑘
𝑗=1
                                                                   
So, as exactly we worked to prove (A.SC.7), we have that 
{1   2   3  …  (𝑘 − 2)    (𝑘 − 1)}RR(n−k) = ∑(−1)
𝑗−1 (
k
k − (k − j)
)
𝑘
𝑗=1
∑ RR(n−k)
( nn−k)
= ∑ RR(n−k)
( nn−k)
∗ ∑(−1)𝑗−1 (
k
j
)
𝑘
𝑗=1
 
                                                                        = ∑ RR(n−k)
( nn−k)
∗ ((
k
0
) − ∑(−1)𝑗 (
k
j
)
𝑘
𝑗=0
) 
                                                                        = ∑ RR(n−k)
( nn−k)
∗ ((
k
0
) − ∑ (
k
j
) (1)𝑘−𝑗 ∗ (−1)𝑗
𝑘
𝑗=0
) 
                                                                        = ∑ RR(n−k)( nn−k)
∗ (1 − (1 − 1)𝑘) = ∑ RR(n−k)( nn−k)
                         
The transformation in the last line was applied because 
∑ (k
j
) (𝑥)𝑘−𝑗 ∗ (𝑦)𝑗𝑘𝑗=0 = (𝑥 + 𝑦)
𝑘, for x=1, y=-1  
 
 
Of note that the same hold for k=n-1 and k=n for RR(1), RR(0) respectively i.e. the total summation of  RR(1) and RR(0)  after replacing all 
RERI(n) up to RERI(n−2) from the recurrence relation (A.SC.3) and ERR(1)= RR(1) − RR(0), 
∑(−1)𝑗−1 (
n − 1
n − 1 − (n − 1 − j)
)
𝑛−1
𝑗=1
∑ RR(n−(n−1))
( nn−(n−1))
= ∑ RR(1)
(n1)
 
and 
∑(−1)𝑗−1 (
n
n − (n − j)
)
𝑛
𝑗=1
∑ RR(n−(n))
( nn−(n))
= RR(0) 
We also note from the (A.SC.17) that in the final solution, the sign changes from + to -  (or vice versa) before each 
∑ RR(k)
(nk)
 
So we have that the final solution for the recurrence relationship (A.SC.3) is 
RERIn(X1, X2, … , Xn) = RR(n) 
                                          − ∑ RR(n−1) 
( nn−1)
 
                                         + ∑ RR(n−2)
( nn−2)
 
                                      ... 
                          +(−1)n ∗ ∑ RR(0)
(n0)
                                                             
or in other words 
RERIn(X1, X2, … , Xn) = ∑ ∑ (−1)
k
( nn−k)
RR(n−k) 
n
k=0
                                                                           𝑸𝑬𝑫 (𝒔𝒆𝒆 𝒆𝒒𝒖𝒂𝒕𝒊𝒐𝒏 𝟔 𝒊𝒏 𝒕𝒉𝒆 𝒕𝒆𝒙𝒕) 
 
 
 
 
 
 
 
 
 
 
 
Proof of expression (6) 
 
Connection between n-way interaction and (n-1) way interactions 
We have to prove expression (7) from the paper, that is 
RERIn(X1, X2, … , Xn) = (RERI𝑛−1(X1, X2, … , Xn|Xi = 1) ∗  RRX1−X2−…Xi+1−Xi+Xi+1−⋯Xi+1−⋯Xn−) − RERI𝑛−1(X1, X2, … , Xn|Xi = 0)         
From equation 6 in the paper, we have that  
RERIn(X1, X2, … , Xn) = RR(n) − ∑ RR(n−1) 
( nn−1)
+ ∑ RR(n−2)
( nn−2)
− ∑ RR(n−3)
( nn−3)
+ ⋯ + (−1)n ∗ ∑ RR(0)
(n0)
 
Using expression (6), we can calculate 
RERI𝑛−1(X1, X2, … , Xn|Xi = 1) =
RR(n);Xi+
−∑ RR(n−1);Xi+ (n−11 )
+∑ RR(n−2);Xi+(n−12 )
…+(−1)n−1∗∑ RR(1);Xi+(n−1n−1)
RRX1−X2−…Xi+1−Xi+Xi+1−⋯Xi+1−⋯Xn
                       (A.SC.18) 
where RR(k);Xi+ , k≤n and i≤n, is the relative risk, when k out of n risk factors are present and among them Xi is present as well. 
In (A.SC.18), using the notation RR(k);Xi+ , we denote the RR when k risk factors are present and n-k are absent and Xi is present 
From the above, it is obvious that the term RR(1);Xi+ is equal to RR(1);Xi+ = RRX1−X2−…Xi+1−Xi+Xi+1−⋯Xi+1−⋯Xn− 
So, from (A.SC.18), we have that 
RERI𝑛−1(X1, X2, … , Xn|Xi = 1) ∗ RRX1−X2−…Xi+1−Xi+Xi+1−⋯Xi+1−⋯Xn− = 
                                                         = RR(n);Xi+ − ∑ RR(n−1);Xi+ (n−11 )
+ ∑ RR(n−2);Xi+(n−12 )
… + (−1)n−1 ∗ ∑ RR(1);Xi+(n−1n−1)
            (A.SC.19) 
In the same fashion, due to expression 6 we have that 
RERI𝑛−1(X1, X2, … , Xn|Xi = 0) = RR(n−1);Xi− − ∑ RR(n−2);Xi− (n−1n−2)
+ ∑ RR(n−3);Xi−(n−1n−3)
… + (−1)n−1 ∗ ∑ RR(0);Xi−(n−10 )
               (A.SC.20) 
where RR(k);Xi− , k≤n and i≤n, is the relative risk, when k out of n risk factors are present and risk factor Xi is absent. 
Now, combining (A.SC.19) and (A.SC.20), we have that 
(RERI𝑛−1(X1, X2, … , Xn|Xi = 1) ∗ RRX1−X2−…Xi+1−Xi+Xi+1−⋯Xi+1−⋯Xn−) − RERI𝑛−1(X1, X2, … , Xn|Xi = 0) = 
= RR(n);Xi+ − ∑ RR(n−1);Xi+ 
(n−11 )
+ ∑ RR(n−2);Xi+
(n−12 )
… + (−1)n−1 ∗ ∑ RR(1);Xi+
(n−1n−1)
 
− (RR(n−1);Xi− − ∑ RR(n−2);Xi− (n−1n−2)
+ ∑ RR(n−3);Xi−(n−1n−3)
… + (−1)n−1 ∗ ∑ RR(0);Xi−(n−10 )
)                                                            
Now if we try to summarize all RR(n−j) terms (1≤j≤n). We have that 
(RERI𝑛−1(X1, X2, … , Xn|Xi = 1) ∗ RRX1−X2−…Xi+1−Xi+Xi+1−⋯Xi+1−⋯Xn−) − RERI𝑛−1(X1, X2, … , Xn|Xi = 0) = RR(n);Xi+ 
                                                                                                                   − (∑ RR(n−1);Xi+ (n−1n−2)
+ RR(n−1);Xi−) 
                                                                                                                   + (∑ RR(n−1);Xi+ (n−1n−3)
+ ∑ RR(n−1);Xi− (n−1n−2)
) 
                                                                                                                   − (∑ RR(n−2);Xi+ (n−1n−4)
+ ∑ RR(n−2);Xi− (n−1n−3)
) 
                                                                                                                                                   … 
                                                                                                                   +(−1)j (∑ RR(n−j);Xi+ (n−1n−j )
+ ∑ RR(n−j);Xi− ( n−1n−(j−1))
) 
                                                                                                                                                   … 
                                                                                                                  +(−1)n−2 (∑ RR(2);Xi+ (n−11 )
+ ∑ RR(2);Xi− (n−12 )
) 
                                                                                                                  +(−1)n−1 (∑ RR(1);Xi+ (n−10 )
+ ∑ RR(1);Xi−(n−11 )
) 
                                                                                                                  +(−1)n (∑ RR(0);Xi−(n−10 )
)                                              (A.SC.21) 
It is obvious from (A.SC.21), that if we prove for all RR(n−j) terms (1≤j≤n) that 
+(−1)j (∑ RR(n−j);Xi+ (n−1n−j)
+ ∑ RR(n−j);Xi− ( n−1n−(j−1))
) = +(−1)j (∑ RR(n−j) ( nn−j)
)                                                                        (A.SC.22) 
then we will have also proved equation (7) in the paper. 
With a closer look at the first part of (A.SC.22), we have that ∑ RR(n−j);Xi+ (n−1n−j )
  and  ∑ RR(n−j);Xi− ( n−1n−(j−1))
share no common RRs, given that 
∑ RR(n−j);Xi+ (n−1n−j )
 is the summation of all the combinations of different RRs, when n-j risk factors are present and j are absent and Xi is present, 
while ∑ RR(n−j);Xi− ( n−1n−(j−1))
is the summation of all the combinations of different RRs, when n-j risk factors are present and j are absent and Xi is 
absent, so there is no overlapping of common RRs in that summation. Moreover, it is know from the Pascal rule that 
(
n − 1
n − j
) + (
n − 1
n − (j − 1)
) = (
n
n − j
) 
So the summation of ∑ RR(n−j);Xi+ (n−1n−j )
  and  ∑ RR(n−j);Xi− ( n−1n−(j−1))
will be equal to ∑ RR(n−j) ( nn−j)
, i.e. the summation of all the combinations of 
different RRs, when n-j risk factors are present and j are absent.                                                                    QED 
 
So (A.SC.22) is proven, which means that expression (7) in the paper is proven as well. 
Section D - Clarifications and recommendations for calculating multi-way interactions 
 
When dealing only with two risk factors, the definition of RERI is pretty straightforward. 
The only issue that we should take into consideration is that RERI is calculated by risk and not 
protective factors. So if any of the binary variables Z1 or Z2 we use in the analysis is a protective 
factor, we need to recode them to a risk factor. For example, if Z1 and Z2 are both protective 
factors, we need to create variables X1=1-Z1 and X2=1-Z2 and calculate RERI(X1,X2). 
Nevertheless, when it is of interest the calculation of higher order interactions on the additive 
scale, we showed that the definitions are getting more complex, so we will try to further 
elaborate on them.  
 
Three-way interactions 
To shed more light in the properties of joint effects of the 3 risk factors of interest, we 
propose the following steps; 
1) Conduct the analysis with the exposure of interest Z1, Z2, Z3, without using any 
interaction term. We run e.g. Cox regression, and we check if the hazard ratios (HR) are 
greater than one (i.e. if the exposures are risk factors). If, for example, we have that 
HR(Z1)>1, HR(Z2)>1, but HR(Z3)<1, (i.e. Z1, Z2 are risk factors, but Z3 is protective), we 
have to use the variables X1=Z1, X2=Z2, and X3=1-Z3. In our illustrative paradigm, we 
didn’t use a variable for the adherence to MD, which is a protective factor for mortality, 
bur for non-adherence to MD instead. 
2) Perform the analysis with the risk factors of interest X1, X2, X3, this time using the 
interaction terms X1X2, X1X3, X2X3 and X1X2X3, as presented in model (A.SB.1) in the 
Appendix (Section B) 
3) Compute TotRERI3(X1,X2 ,X3) (from A.SB.2, Appendix, Section B) and find out whether 
the effects of X1, X2, X3 are super-additive (TotRERI3(X1,X2 ,X3)>0), additive 
(TotRERI3(X1,X2 ,X3)=0) or sub-additive (TotRERI3(X1,X2 ,X3)<0). In our example, we 
show that the effects of low MD, obesity, and current smoking are super-additive 
(TotRERI3(X1,X2 ,X3)=1.20>0). 
4) Estimate RERI3(X1,X2 ,X3) (from A.SB.3, Appendix, Section B) to check whether any 
deviation from additivity of the three risk factors (TotRERI3(X1,X2 ,X3)) is attributed to 
the 3-way interaction, beyond the two way interactions, given that the 3
rd
 risk factor is 
absent [see equation (3)]. In our example, there was evidence for 3-way additive 
interaction of the risk factors, beyond their two way interactions.  
5) Calculate RERI2(X1,X2 |X3=0), RERI2(X1,X3 |X2=0) and RERI2(X2,X3 |X1=0)  [from 
(A.SB.4) - (A.SB.6), Appendix, Section B) to test whether any deviation from additivity 
of the three risk factors (expressed through TotRERI3(X1,X2 ,X3)) is attributed to additive 
interaction of the two risk factors [(see equation (3)], when the third is absent. In our 
paradigm, all RERI2 given the absence of the 3
rd
 risk factor were negative, but of small 
magnitude and not statistically significant. 
6) Compute RERI2(X1,X2 |X3=1), RERI2(X1,X3 |X2=1) and RERI2(X2,X3 |X1=1) (from 
(A.SB.7) – (A.SB.9) in Appendix, Section B) to check to what extend the interaction due 
to three risk factors exclusively (i.e RERI3(X1,X2 ,X3))  can be interpreted as interaction 
of the two risk factors, given that the 3
rd
 is present.  If we combine that information with 
the one from step 5, we can additionally check whether RERI2’s remain constant across 
the strata of the 3
rd
 risk factor of interest. In our paradigm, we observed that all RERI2 
were positive, given the presence of the 3
rd
 risk factor. If we additionally take into 
consideration RERI2’s given the absence of the 3
rd
 risk factor (from the previous step), 
we draw the conclusion that there is difference in how two of these variables interact 
across the levels of the 3
rd
 factor.  
7) Check for qualitative interaction, i.e. whether  
a) the risk of X1 is increasing across the strata of X2 and X3, i.e. 
RRX1+X2+X3+ >  RRX1−X2+X3+    ,    RRX1+X2+X3− >  RRX1−X2+X3− , 
RRX1+X2−X3+ >  RRX1−X2−X3+   and RRX1+X2−X3− >  RRX1−X2−X3−  
b) the risk of X2 is increasing across the strata of X1 and X3, i.e. 
RRX1+X2+X3+ >  RRX1+X2−X3+    ,    RRX1+X2+X3− >  RRX1+X2−X3−  ,     
 RRX1−X2+X3+ > RRX1−X2−X3+    and RRX1−X2+X3− >  RRX1−X2−X3−  
c) the risk of X3 is increasing across strata of X1 and X2, i.e. 
RRX1+X2+X3+ >  RRX1+X2+X3−    ,    RRX1+X2−X3+ >  RRX1+X2−X3−   ,    
 RRX1−X2+X3+ >  RRX1−X2+X3−  and RRX1−X2−X3+ >  RRX1−X2−X3−  
 For more details on qualitative interaction, please see Section F 
 
 
n-way interactions 
The total relative excess risk due to interaction (TotRERIn) is calculated by comparing the 
joint effect of all n risk factors to the situation when each one acts separately (expression 5). 
However, TotRERIn is affected by all lower-order interactions of the n risk factors and not 
exclusively by the n-way interaction of the risk factors. From equation (A.SC.2), we observe that 
the sign and magnitude of TotRERIn depends on the sign and magnitude of 
∑ RERIn−1(X1, X2, … , Xn|1 of the Xi = 0)( nn−1)
, ∑ RERIn−2(X1, X2, … , Xn|2 of the Xi = 0)( nn−2)
, …, 
∑ RERI2(X1, X2, … , Xn|(n − 2) of the Xi = 0)(n2)
. So, RERIn(X1, X2, … , Xn) measures the interaction 
between n risk factors on the additive scale, as this index does not account for all the lower order 
additive interactions. To shed more light in the properties of joint effects of the n risk factors, we 
propose the following steps; 
1) Apply step 1 as in recommendations in the 3-way interactions section, this time for Z1, 
Z2, …, Zn. From this step, we will end up with the risk factors X1, X2, …, Xn. 
2) Include all possible 2,3,…,n product terms constructed by X1, X2, …, Xn in the model, as 
described in step 2 in recommendations in the 3way interactions section. 
3) Calculate TotRERIn(X1,X2 ,…,Xn) from expression (5). 
4) Calculate RERIn(X1,X2 ,…,Xn) from equation (6) 
5) Compute all RERIn-1 given the 1 risk factor is absent 
(RERIn−1(X1, X2, … , Xn|1 of the Xi = 0)) from expression (6). 
6) Estimate all RERIn-1 given the 1 risk factor is present 
(RERIn−1(X1, X2, … , Xn|1 of the Xi = 1)) from equation (A.SC.19) 
7) We can additionally compute all TotRERIn-k and RERIn-k , 2≤k≤n-2, given k risk factors 
are all absent (TotRERIn−k(X1, X2, … , Xn|k of the Xi = 0) and 
 RERIn−k(X1, X2, … , Xn|k of the Xi = 0)) to understand how and under which conditions 
the n-k risk factors interact for the development of a specific disease. On the same 
fashion, we can compute all TotRERIn−k(X1, X2, … , Xn|k of the Xi = 1) and 
RERIn−k(X1, X2, … , Xn|k of the Xi = 1)  
8) Check for qualitative interaction, that is 
whether the risk of X1 is increasing across the strata of X2, X3 … Xn,. 
whether the risk of X2 is increasing across the strata of X1, X3 … Xn,  
… 
whether the risk of Xn is increasing across the strata of X1, X2 … Xn-1 
 
 
 
 
Section E – Multiplicative interaction and its connection to additive interaction 
2-way interactions 
The usual practice of the researchers is to refer to statistical interaction when studying interaction 
between risk factors.  Nevertheless, under this concept, interaction is measured on either additive 
or multiplicative scale, depending on the form of the underlying model used. It is known in the 
study of the 2-way interactions that then we use Cox or logistic regression, which are inherently 
multiplicative models, then the beta coefficient of the product term shows whether there is any 
deviation from the multiplicativity of the effects of two risk factors. More specifically, the effects 
are super- or sub-multiplicative, if the beta coefficient is greater or lower than zero respectively 
(or, equivalently, if the odds/hazard ratio is higher or lower than 1). For example, if we run a Cox 
regression model with exposures X1 and X2, i.e. 
λ(t) = λ0(t) ∗ exp⁡(b1X1 + b2X2 + b3X1X2) ,    (A.SE.1) 
then, we calculate 
𝐻𝑅(X1 = 0, X2 = 0) = RRX1−X2− = 1 
𝐻𝑅(X1 = 1, X2 = 0) = RRX1+X2− = exp(b1) 
𝐻𝑅(X1 = 0, X2 = 1) = RRX1−X2+ = exp(b2) 
𝐻𝑅(X1 = 1, X2 = 1) = RRX1+X2+ = exp(b1 + b2 + b3) 
Then the multiplicative interaction 
I2 =
RRX1+X2+
RRX1+X2−∗RRX1−X2+
= exp(b3) ,        (A.SE.2) 
  
So from (A.SE.2), the effects are super-multiplicative (I2>1), if b3>0,  
the effects are multiplicative (I2=1), if b3=0 and  
the effects are sub-multiplicative (I2<1), if b3<0,  
that is, the statistical interaction will show whether there is any deviation from multiplicativity of 
the effects. 
Regarding the connection between multiplicative and additive 2-way interaction, there are 2 
inequalities that link the deviation from additivity and from multiplicativity. Both of them hold 
when there is no qualitative interaction. They also hold if we relax the assumptions of qualitative 
interaction and we assume only that RRX1+X2− > RRX1−X2−(= 1) and 
 RRX1−X2+ > RRX1−X2−(= 1) 
  
1)  When the effects of 2 risk factors are either multiplicative of super-multiplicative, then the 
effects will be super-additive.  
Proof: We have that  
RERI2(X1, X2) = RRX1+X2+ −RRX1+X2− −RRX1−X2+ + 1   ,    (A.SE.3) 
In the case of multiplicative or super-multiplicative effects of X1 and X2, i.e. when I2≥1, from 
(A.SE.2),  RRX1+X2+ ≥ RRX1+X2− ∗ RRX1−X2+, so from (A.SE.3) we have 
RERI2(X1, X2) ≥ RRX1+X2− ∗ RRX1−X2+ − RRX1+X2− − RRX1−X2+ + 1    
                         = RRX1+X2− ∗ (RRX1−X2+ − 1) − (RRX1−X2+ − 1) 
                         = (RRX1+X2− − 1) ∗ (RRX1−X2+ − 1) > 0  
 
because RRX1+X2−⁡and⁡RRX1+X2− > 1, as X1 and X2 are risk factors. In other words, we proved 
that when the effects of 2 risk actors are either multiplicative of super-multiplicative, then the 
effects will be super-additive. 
 2)  When the effects of 2 risk factors are either additive or sub-additive, then the effects will be 
sub-multiplicative.  
Proof: If  RERI2(X1, X2) ≤ 0, then RRX1+X2+ ≤ RRX1+X2− + RRX1−X2+ − 1   , so  
RRX1+X2+
RRX1+X2−+RRX1−X2+−1
≤ 1     (A.SE.4),  
so we have to prove that 
RRX1+X2− + RRX1−X2+ − 1 < RRX1+X2− ∗ RRX1−X2+, or equivalently 
RRX1+X2− ∗ RRX1−X2+−RRX1+X2− − RRX1−X2+ + 1 > 0 or equivalently 
(RRX1+X2− − 1) ∗ (RRX1−X2+ − 1) > 0, which is true 
So from (A.SE.4), we have that 
I2 =
RRX1+X2+
RRX1+X2− ∗ RRX1−X2+
<
RRX1+X2+
RRX1+X2− + RRX1−X2+ − 1
≤ 1 
So, I2<1. In other words, we proved that when the effects of 2 risk factors are either additive or 
sub-additive, then the effects will be sub-multiplicative. 
 
3-way interactions 
In case of study of 3-way interaction on the multiplicative scale, we should extend the definitions to 
three risk factors X1, X2 and X3. We will use the worked example from our paper, that is we will use 
the Cox regression model (A.SB.1). 
For the deviation from multiplicativity of the effects of these factors, one should compare 
RRX1+X2+X3+⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡vs⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡RRX1+X2−X3− ∗⁡⁡RRX1−X2+X3− ⁡⁡ ∗ ⁡⁡RRX1−X2−X3+⁡⁡⁡⁡ 
 
So, we can calculate TotI3(X1, X2, X3) to check if there is any deviation from multiplicativity 
TotI3(X1, X2, X3) =
RRX1+X2+X3+
RRX1+X2−X3−∗RRX1−X2+X3−∗RRX1−X2−X3+
⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡(A.SE.5) 
So we have that 
TotI3(X1, X2, X3) =
exp(a1+a2+a3+a4+a5+a6+a7)
exp(a1)∗exp(a2)∗exp(a3)
= exp(a4 + a5 + a6 + a7)         (A.SE.6) 
On the same fashion, the 2-way multiplicative interaction, given the third factor is absent will be 
I2(X1, X2|X3 = 0) = ⁡
exp(a1+a2+a4)
exp(a1)∗exp(a2)
= exp(a4)                  (A.SE.7) 
I2(X1, X3|X2 = 0) = ⁡
exp(a1+a3+a5)
exp(a1)∗exp(a3)
= exp(a5)                  (A.SE.8) 
I2(X2, X3|X1 = 0) = ⁡
exp(a2+a3+a6)
exp(a1)∗exp(a2)
= exp(a6)                 (A.SE.9) 
 
Moreover, the 2-way multiplicative interaction, given the third factor is present will be 
I2(X1, X2|X3 = 1) = ⁡
exp(a1+a2+a3+a4+a5+a6+a7)/exp(a3)
(
exp(a1+a3+a5)
exp(a3)
)∗(
exp(a2+a3+a6)
exp(a3)
)
= exp(a4 + a7)                (A.SE.10) 
I2(X1, X3|X2 = 1) = ⁡
exp(a1+a2+a3+a4+a5+a6+a7)/exp(a2)
(
exp(a1+a2+a4)
exp(a2)
)∗(
exp(a2+a3+a6)
exp(a2)
)
= exp(a5 + a7)                 (A.SE.11) 
I2(X2, X3|X1 = 1) = ⁡
exp(a1+a2+a3+a4+a5+a6+a7)/exp(a1)
(
exp(a1+a2+a4)
exp(a1)
)∗(
exp(a1+a3+a5)
exp(a1)
)
= exp(a6 + a7)                 (A.SE.12) 
 
and the 3-way multiplicative interaction, beyond the 2-way interactions will be 
I3(X1, X2, X3) =
TotI3(X1, X2, X3)
I2(X1, X2|X3 = 0) ∗ I2(X1, X3|X2 = 0) ∗ I2(X2, X3|X1 = 0)
 
And if we make the calculations 
I3(X1, X2, X3) = exp(a7)                                                            (A.SE.13) 
 
 
n-way interactions 
By extending the definitions of checking for deviation from multiplicativity to the n-way 
interactions, we have that one should compare 
RRX1+X2+⋯Xn+⁡⁡⁡⁡⁡vs⁡⁡⁡⁡⁡⁡RRX1+X2−⋯Xn− ∗ ⁡⁡RRX1−X2+X3−⋯Xn− ⁡ ∗ …⁡∗ ⁡⁡RRX1−X2−⋯Xn−1−Xn+⁡⁡⁡⁡ 
We can calculate TotI𝑛(X1, X2, … , Xn) to check if there is any deviation from multiplicativity 
TotI𝑛(X1, X2, … , Xn) =
RRX1+X2+⋯Xn+
RRX1+X2−⋯Xn−∗⁡⁡RRX1−X2+X3−⋯Xn−⁡∗…⁡∗⁡⁡RRX1−X2−⋯Xn−1−Xn+
     (A.SE.14) 
To check deviation from additivity, we have from equation (5) that we have to check 
TotRERI𝑛(X1, X2, … , Xn) = RRX1+X2+⋯Xn+ − RRX1+X2−⋯Xn− 
⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡⁡−RRX1+X2−⋯Xn− −⋯− RRX1−X2−⋯Xn−1−Xn+ + (n − 1)       (A.SE.15) 
We will generalize the inequalities we showed for 2-way interactions to the n-way interactions. 
Both of them hold when there is no qualitative interaction. They also hold if we relax the 
assumptions of qualitative interaction and we assume only that  
RRX1+X2−⋯Xn− > RRX1−X2−⋯Xn−(= 1)       and 
RRX1−X2+X3−⋯Xn− > RRX1−X2−⋯Xn−(= 1)  and 
… 
RRX1−X2−⋯Xn−1−Xn+ > RRX1−X2−⋯Xn−(= 1) 
More specifically, we will prove 
1)  When the effects of n risk factors are either multiplicative of super-multiplicative, then the 
effects will be super-additive.  
Proof: If TotI𝑛(X1, X2, … , Xn) ≥ 1, we have that 
TotRERI𝑛(X1, X2, … , Xn) ≥ RRX1+X2−⋯Xn− ∗⁡⁡RRX1−X2+X3−⋯Xn− ⁡ ∗ …⁡∗⁡⁡RRX1−X2−⋯Xn−1−Xn+ 
                         −RRX1+X2−⋯Xn− − RRX1−X2+X3−⋯Xn− −⋯− RRX1−X2−⋯Xn−1−Xn+ + (n − 1)             
Now we have to prove that 
RRX1+X2−⋯Xn− ∗ ⁡⁡RRX1−X2+X3−⋯Xn− ⁡ ∗ …⁡∗ ⁡⁡RRX1−X2−⋯Xn−1−Xn+ 
−RRX1+X2−⋯Xn− − RRX1−X2+X3−⋯Xn− −⋯− RRX1−X2−⋯Xn−1−Xn+ + (n − 1) > 0      (A.SE.16) 
We have that 
RRX1+X2−⋯Xn− ∗⁡⁡RRX1−X2+X3−⋯Xn− ⁡ ∗ …⁡∗ ⁡⁡RRX1−X2−⋯Xn−1−Xn+ 
−RRX1+X2−⋯Xn− − RRX1−X2+X3−⋯Xn− −⋯− RRX1−X2−⋯Xn−1−Xn+ + (n − 1) =       
 
1
st
  step  remove RRX1+X2−⋯Xn− from the equation 
 
= RRX1+X2−⋯Xn− ∗⁡⁡ (RRX1−X2+X3−⋯Xn− ⁡ ∗ …⁡∗ ⁡⁡RRX1−X2−⋯Xn−1−Xn+ − 1) 
−RRX1−X2+⋯Xn− −⋯− RRX1−X2−⋯Xn−1−Xn+ + (n − 1) >         (because RRX1+X2−⋯Xn− > 1) 
(RRX1−X2+X3−⋯Xn− ⁡ ∗ …⁡∗ ⁡⁡RRX1−X2−⋯Xn−1−Xn+ − 1) 
−RRX1−X2+⋯Xn− −⋯− RRX1−X2−⋯Xn−1−Xn+ + (n − 1) =       
(RRX1−X2+X3−⋯Xn− ⁡ ∗ …⁡∗ ⁡⁡RRX1−X2−⋯Xn−1−Xn+) 
−RRX1−X2+⋯Xn− −⋯− RRX1−X2−⋯Xn−1−Xn+ + (n − 2) =       
 
2
nd
 step  remove RRX1−X2+X3−⋯Xn− from the equation 
 
= RRX1−X2+X3−⋯Xn− ∗ ⁡⁡ (RRX1−X2−X3+X4−⋯Xn− ⁡ ∗ …⁡∗ ⁡⁡RRX1−X2−⋯Xn−1−Xn+ − 1) 
−RRX1−X2−X3+X4−⋯Xn− −⋯− RRX1−X2−⋯Xn−1−Xn+ + (n − 2) >         (because RRX1−X2+X3−⋯Xn− > 1) 
(RRX1−X2−X3+X4−⋯Xn− ⁡ ∗ …⁡∗ ⁡⁡RRX1−X2−⋯Xn−1−Xn+ − 1) 
−RRX1−X2+⋯Xn− −⋯− RRX1−X2−⋯Xn−1−Xn+ + (n − 2) =       
(RRX1−X2−X3+X4−⋯Xn− ⁡ ∗ …⁡∗ ⁡⁡RRX1−X2−⋯Xn−1−Xn+) 
−RRX1−X2+⋯Xn− −⋯− RRX1−X2−⋯Xn−1−Xn+ + (n − 3) >       
… 
 
(n-2)
th
  step  remove RRX1−X2−⋯Xn−3−Xn−2+Xn−1−Xn− from the equation) 
 
RRX1−X2−⋯Xn−3−Xn−2+Xn−1−Xn− ∗⁡⁡ (RRX1−X2−⋯Xn−2−Xn−1+Xn− ⁡ ∗ ⁡RRX1−X2−⋯Xn−1−Xn+ − 1) 
−RRX1−X2−⋯Xn−2−Xn−1+Xn− − RRX1−X2−⋯Xn−1−Xn+ + (n − (n − 2)) >      
(because RRX1−X2−⋯Xn−3−Xn−2+Xn−1−Xn− > 1) 
(RRX1−X2−⋯Xn−2−Xn−1+Xn− ⁡ ∗ ⁡RRX1−X2−⋯Xn−1−Xn+ − 1) 
−RRX1−X2−⋯Xn−2−Xn−1+Xn− − RRX1−X2−⋯Xn−1−Xn+ + (n − (n − 2)) = 
(RRX1−X2−⋯Xn−2−Xn−1+Xn− ⁡ ∗ ⁡RRX1−X2−⋯Xn−1−Xn+) 
−RRX1−X2−⋯Xn−2−Xn−1+Xn− − RRX1−X2−⋯Xn−1−Xn+ + 2 − 1 = 
(RRX1−X2−⋯Xn−2−Xn−1+Xn− ⁡ ∗ ⁡RRX1−X2−⋯Xn−1−Xn+) 
−RRX1−X2−⋯Xn−2−Xn−1+Xn− − RRX1−X2−⋯Xn−1−Xn+ + 1 = 
(RRX1−X2−⋯Xn−2−Xn−1+Xn−⁡) ∗ (⁡RRX1−X2−⋯Xn−1−Xn+ − 1) − (RRX1−X2−⋯Xn−1−Xn+ − 1) = 
(RRX1−X2−⋯Xn−2−Xn−1+Xn− − 1) ∗ (⁡RRX1−X2−⋯Xn−1−Xn+ − 1) > 0 
 
because RRX1−X2−⋯Xn−2−Xn−1+Xn−⁡𝑎𝑛𝑑⁡RRX1−X2−⋯Xn−1−Xn+ > 1  
So, we proved that when the effects of n risk factors are either multiplicative of super-
multiplicative, then the effects will be super-additive. 
 
2)  When the effects of n risk factors are either additive or sub-additive, then the effects will be 
sub-multiplicative.  
Proof: If  TotRERIn(X1, X2, … , Xn) ≤ 0, then 
RRX1+X2−⋯Xn− ∗ ⁡⁡RRX1−X2+X3−⋯Xn− ⁡ ∗ …⁡∗ ⁡⁡RRX1−X2−⋯Xn−1−Xn+ 
−RRX1+X2−⋯Xn− − RRX1−X2+X3−⋯Xn− −⋯− RRX1−X2−⋯Xn−1−Xn+ + (n − 1) ≤ 0 
or equivalently 
RRX1+X2−⋯Xn−∗⁡⁡RRX1−X2+X3−⋯Xn−⁡∗…⁡∗⁡⁡RRX1−X2−⋯Xn−1−Xn+
RRX1+X2−⋯Xn−+RRX1−X2+X3−⋯Xn−+⋯+RRX1−X2−⋯Xn−1−Xn+−(n−1)
≤ 1    (A.SE.17) 
From (A.SE.14), we have that 
TotI𝑛(X1, X2, … , Xn) =
RRX1+X2+⋯Xn+
RRX1+X2−⋯Xn− ∗ ⁡⁡RRX1−X2+X3−⋯Xn− ⁡ ∗ …⁡∗ ⁡⁡RRX1−X2−⋯Xn−1−Xn+
< 
(because of (A.SE.16)) 
RRX1+X2−⋯Xn−∗⁡⁡RRX1−X2+X3−⋯Xn−⁡∗…⁡∗⁡⁡RRX1−X2−⋯Xn−1−Xn+
RRX1+X2−⋯Xn−+RRX1+X2−⋯Xn−+⋯+RRX1−X2−⋯Xn−1−Xn+−(n−1)
≤ 1    because of (A.SE.17) 
So we proved that when TotRERIn(X1, X2, … , Xn) ≤ 0, then TotI𝑛(X1, X2, … , Xn) < 1. In other 
words, we showed that when the effects of n risk factors are either additive or sub-additive, then 
the effects will be sub-multiplicative. 
 
 
Connection between deviation from additivity and multiplicativity from the worked example 
 
We can calculate TotI3=1.20>1 from (A.SE.6), so the effects of low MD, obesity and smoking 
status on mortality are super-multiplicative (even not statistically significant), meaning that we 
also expect that these effects would also be super-additive (from the 1st inequality). This is true, 
because TotRERI3=1.20>0, in other words, there is an excess 120% risk due to the joint presence 
of all risk factors, compared to the situation that each of them would act separately 
The 3-way interaction of these factors beyond the 2-way interactions was positive both under the 
additive and under the multiplicative scale (RERI3=1.98 and I3=2.51), however there is not a 
direct link between these two indeces. The only conclusion that we can infer from equations 
(A.SB3) and (A.SE13) is that the greater the value of I3 is, the greater the value of RERI3 will be 
as well (the opposite is not always true), without any guarantee that RERI3 will be positive, 
depending on a specific value for I3. 
Moreover, all the RERI2 given the absence of the 3
rd
 risk factor are negative, indicating that the 
corresponding all the effects between 2 risk factors, when the 3
rd
 is absent, will be sub-
multiplicative (from the 2
nd
 inequality). More specifically, we had that 
I2(low MD, high BMI / never or former smokers)=0.77<1 
I2(low MD, current smokers / low BMI)= 0.79<1 
I2(high BMI, current smokers / high MD)= 0.79<1 
Regarding the 2-way interactions, when the 3
rd
 factor was present, when we calculate that all the 
I2‘s, we find that the effects of every 2 risk factors, when the 3
rd
 is present, were super-
multiplicative; 
I2(low MD, high BMI / current smokers)=1.98>1 
I2(low MD, current smokers / high BMI)= 1.99>1 
I2(high BMI, current smokers / low MD)= 1.92>1 
indicating that the corresponding effects will be super-additive, that’s why all RERI2’s were positive. 
 
In this example, we found that the interpretation doesn’t change, if we convert to deviation from 
multiplicativity as reference. However, this is not always true. We showed above that 
1) If TotI3≥1  → TotRERI3>0  and 
2) If TotRERI3≤0  → TotI3<1   
The opposite in these relationships does not always hold. In other words, it is possible to observe super-
additive effects, which can be sub-multiplicative (TotRERI3>0 & TotI3<1) 
We also mentioned that the greater the value of I3 is, the greater the value of RERI3 will be. 
Nevertheless, there is no specific interval lower limit for RERI3 for different values of I3. 
Section F – Qualitative interaction 
 
 
We refer to the term qualitative (or cross-over) interaction when the exposure of interest is a risk 
factor for a specific outcome for one subgroup, but a protective factor for another subgroup. For 
example, a specific medication might be beneficial in younger people, but not in the elderly. 
Qualitative interaction is very crucial for decision making for public health purposes, because, in 
such instances, we should not treat all the subgroups, but only those people for which the 
medication is beneficial.   
 
To check for qualitative interaction in case of 2 risk factors X1 and X2, we should check  
1) Whether the risk of X1 is increasing across the strata of X2, i.e. 
RRX1+X2+ >  RRX1−X2+          and     RRX1+X2− > RRX1−X2−          
and 
2) Whether the risk of X2 is increasing across the strata of X1, i.e. 
RRX1+X2+ >  RRX1+X2−          and      RRX1−X2+ > RRX1−X2−          
 
To apply the same in case of 3 risk factors X1, X2 and X3, we should check  
1) whether the risk of X1 is increasing across the strata of X2 and X3, i.e. 
RRX1+X2+X3+ >  RRX1−X2+X3+    ,    RRX1+X2+X3− >  RRX1−X2+X3−     ,    RRX1+X2−X3+ >  RRX1−X2−X3+    
and RRX1+X2−X3− >  RRX1−X2−X3−  
2) whether the risk of X2 is increasing across the strata of X1 and X3, i.e. 
RRX1+X2+X3+ >  RRX1+X2−X3+    ,    RRX1+X2+X3− >  RRX1+X2−X3−     ,    RRX1−X2+X3+ >  RRX1−X2−X3+    
and RRX1−X2+X3− >  RRX1−X2−X3−  
3) whether the risk of X3 is increasing across strata of X1 and X2, i.e. 
RRX1+X2+X3+ >  RRX1+X2+X3−    ,    RRX1+X2−X3+ >  RRX1+X2−X3−     ,    RRX1−X2+X3+ >  RRX1−X2+X3−    
and RRX1−X2−X3+ >  RRX1−X2−X3−  
 
The same procedure should be followed for multi-way interactions, i.e. to check 
1) whether the risk of X1 is increasing across the strata of X2, X3 … Xn,. 
2) whether the risk of X2 is increasing across the strata of X1, X3 … Xn,  
… 
n) whether the risk of Xn is increasing across the strata of X1, X2 … Xn-1 
 
In Section C of the Appendix, we show how these calculations can be applied in Stata, in case of 
3 risk factors, X1, X2 and X3. 
 
Qualitative interaction occurs very rarely in the study of the joint effects of 2 risk factors, that’s 
why it is not mentioned in the literature frequently. It is very likely to happen rarely in the case 
of 3 risk factors as well, but it is more possible to occur when studying more >3 risk factors (the 
more we increase the factors of interest, the more likely to observe qualitative interactions)  
So, when conducting a multi-way interaction analysis, we should additionally test whether the 
risk of a risk factor, is increasing across the different subgroups of interest of the population.  
In other words, a researcher should assess the results from the interaction analysis (TotRERI and 
RERIs), as we did in the main body of the manuscript, and additionally test whether there is 
qualitative interaction. In the case that qualitative interaction exists, then one should comment on 
the corresponding consequences (e.g. that a specific medication is protective for CVD in one 
subgroup of the study while it is not in another), apart from the discussion of the results of 
interaction analysis (RERIs and TotRERIs).  
